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Abstract 
Transforming growth factor β (TGF-β) is an important cytokine responsible for a 
wide range of different cellular functions including extracellular matrix formation, 
angiogenesis and epithelial-mesenchymal transition. We have sought to use self-
assembling DNA nanostructures to influence TGF-β signaling. 
The predictable Watson Crick base pairing allows for designing self-assembling 
nanoscale structures using oligonucleotides.  We have used the method of DNA origami 
to assemble structures functionalized with multiple peptides that bind TGF-β receptors 
outside the ligand binding domain. This allows the nanostructures to cluster TGF-β 
receptors and lower the energy barrier of ligand binding thus sensitizing the cells to 
TGF-β stimulation. To prove efficacy of our nanostructures we have utilized 
immunofluorescent staining of Smad2/4 in order to monitor TGF-β mediated 
translocation of Smad2/4 to the cell nucleus. We have also utilized Smad2/4 responsive 
luminescence constructs that allows us to quantify TGF-β stimulation with and without 
nanostructures.  Our data demonstrate that these functionalized nanostructures are 
capable of sensitizing cells to TGF-β stimulation and stimulating cellular response at 
much lower TGF-β concentration. 
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To functionalize our nanostructures we relied on biotin-streptavidin linkages. 
This introduces a multivalency that is not necessarily desirable in all designs. Therefore 
we have investigated alternative means of functionalization.  
The first approach is based on targeting DNA nanostructure by using zinc finger 
binding proteins. Efficacy of zinc finger binding proteins was assayed by the use of 
enzyme-linked immunosorbent (ELISA) assay and atomic force microscopy (AFM). 
While ELISA indicated a relative specificity of zinc finger proteins for target DNA 
sequences AFM showed a high degree of non-specific binding and insufficient affinity.  
The second approach is based on using peptide nucleic acid (PNA) incorporated 
in the nanostructure through base pairing. PNA is a synthetic DNA analog consisting of 
a backbone of repeating N-(2-aminoethyl)-glycine units to which purine and pyrimidine 
bases are linked by amide bonds. The solid phase synthesis of PNA allows for 
convenient extension of the backbone into a peptide segment enabling automatic 
peptide functionalization of DNA nanostructures. Using biotinylation and AFM, we 
have investigated how the neutral character of the PNA backbone and the addition of 
positive lysine residues alters the incorporation in DNA-based nanostructures compared 
to a DNA control. Results indicate that PNA can successfully be used to functionalize 
DNA nanostructures and encourage future studies combining PNA functionalization 
and cell receptor stimulation.
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1. Introduction  
The start of nanotechnology is famously credited to Richard Feynman’s speech in 1959 
entitled “There is Plenty of Room at the Bottom” [feynman1959]. In this speech Feynman 
outlines how the laws of physics should allow for smaller and smaller miniaturization to 
the point where the Encyclopedia Britannica could be written on the head of a pin and 
machines could be made small enough to perform in situ medical procedures. 
Feynman found part of his inspiration in biology. This was likewise the starting 
point for K. E. Drexler’s 1981 paper on molecular engineering.1 In this paper Drexler 
envisioned an approach to molecular manufacturing inspired by protein-based cellular 
machinery, arguing that the ability to design protein molecules would enable the 
construction of molecular machines capable of general three-dimensional molecular 
syntheses.  
We can conveniently label this approach – one guided by biological principles – as 
bionanotechnology, an approach that finds inspiration in biology to accomplish 
nanotechnological goals like the ones imagined by Feynman.  
But what does it mean to be inspired or guided by biology in this context? If we 
think about cells, they not only define life as we know it, they also represent the most 
complex and diverse manufacturing systems we know. Relying on a myriad of different 
energy sources, cells can transform a vast range of input material to an equally vast 
range of output material while perceiving and responding to informational stimuli. An 
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essential mechanism in this process is molecular recognition and self-assembly at the 
nanoscale, as exemplified by the way proteins fold and the way enzymes recognize their 
substrates.2 Bionanotechnology seeks to utilize these principles of self-assembly to 
develop technologies that mimic the capabilities of living cells in production and in 
information processing. Unlike the historical approach of milling down a macroscale 
unit with finer and finer tools, the use of self-assembly leads to a bottom-up style of 
manufacturing where individual nanoscale units come together to form micro- or 
macroscale assemblies.  
As addressed by Drexler, the principal medium of cellular machinery is 
polypeptides. From an engineering point of view, this presents a problem, as protein 
folding is not yet fully understood, so we cannot yet design novel proteins with desired 
structures (let alone desired functions).3 A solution to this problem, which many 
researchers have seized on, is to use the biological polymer deoxyribonucleic acid 
(DNA) as a molecular building material instead of polypeptides. DNA molecules form 
duplex helices based on Watson and Crick base-pairing.4 A one-dimensional helix can be 
expanded into two and even three dimensions by designing DNA molecules that anneal 
to form branched-junction structures. The use of DNA as a structural material has 
resulted in the design and construction of a sufficient number of DNA-based nanoscale 
structures and devices to merit the label “structural DNA nanotechnology.” This is the 
area in which the present dissertation is principally engaged. The predictable self-
 3 
assembling behavior of DNA enables the construction of highly complex three-
dimensional nanoscale structures in a way that could not be accomplished at present 
using de novo designed proteins as the molecular construction material. Additionally, by 
utilizing the principle of toehold-mediated strand displacement, an astonishing range of 
dynamical functions can be incorporated in structures and devices.5 
 Still, a point of criticism that can be brought against DNA-based nanotechnology is 
that DNA does not serve any structural role in biology and it does not possess the 
diversity of chemical groups that polypeptides have. One could argue that since DNA-
based nanotechnology does not directly imitate the nanotechnology of biology, which is 
principally based on polypeptides for structural and chemical tasks, it cannot hope to 
achieve the capabilities of biological systems. To counter this objection one can point to 
history and the many examples of biology inspiring non-biological technologies. Indeed 
North Carolina has laid claim to perhaps one of the most noteworthy examples. Here in 
the state of North Carolina, 110 years ago, the brothers Wilbur and Orville Wright 
changed the course of history when they performed the first controlled, powered and 
sustained heavier-than-air flight amongst the sand dunes of the outer banks.6 The 
Wright brothers’ fancy with powered flight followed many more and less elegant 
attempts at flying. It also sprang from the ubiquitous human admiration of birds and 
their ability to soar in the skies above us. The brothers spent much time studying birds 
in the hopes of elucidating the secret of flight. However, in the end the fixed bi-wing 
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airplane design of the first Wright Flyer, while relying on universal principles of 
aerodynamics, was far removed from the flapping wings of a bird. Yet it, and its 
successors, proved capable of heralding an era of powered heavier-than-air human 
flight. 
In a similar fashion DNA self-assembly represents an approach for creating three 
dimensional organic structures with nanoscale accuracy that doesn’t look quite like 
anything we see in nature. Still, it is the capability of biological systems to inspire and 
drive development of bionanotechnology. With this in mind it is pertinent to consider 
the biological properties of DNA as they form the basis for the nanotechnological 
potential of the polymer.  A review of the overall biological properties of DNA may also 
suggest subject areas and biological subsystems which could be potential targets for 
manipulation or study using the molecular tools currently being developed within the 
field of structural DNA nanotechnology. 
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2. Biological Properties of DNA 
The potential for DNA as a nanoscale construction material is underpinned by its 
biological properties. In biology DNA is the primary information carrier. Its role can be 
summed up in the central dogma which states that DNA codes for DNA and for RNA 
and RNA codes for proteins.7 That DNA codes for DNA is evident in the way that 
hereditary information is passed on from parent to progeny. To understand what the 
rest of the dogma means, we have to know that RNA (ribonucleic acid) is a molecule 
structurally similar to DNA except it has a hydroxyl group at the 2’ ribose position in 
place of DNA’s hydrogen. A given DNA sequence will thus have a complementary 
RNA sequence to which it can anneal. In this way, a piece of DNA sequence – such as a 
gene – can be transcribed into a complementary RNA sequence, which can then be 
translated into a specific protein. Proteins are biological polymers made from 20 types of 
amino acids, and for any triplet of nucleobases (a codon), the genetic code specifies a 
specific amino acid. Proteins are the structural and catalytic ‘machines’ of living cells 
and thus determine the actions and makeup of the cell. In the following, we will look at 
how the properties of DNA are intimately tied to its role as the information carrier in 
living cells. 
2.1 DNA in Cells and Molecular Cloning 
The central dogma is a universal characteristic of all life as we know it. However, 
when considering the biological properties of DNA in more detail, we have to 
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differentiate between the major classifications of life. Biologists group different forms of 
life based on their similarity and relationship. Humans are distinct from apes but more 
closely related to them than they are to dogs. All three are distinct from plants and again 
these four share characteristics distinct from an Escherichia coli bacterium. At the very 
root of the classification of life, we find three so-called domains. These are Archaea, 
Bacteria, and Eucarya with members of Eucarya often referred to as eukaryotes .8 
Members of all three domains have the cell as the basic unit of life. A cell is a lipid 
membrane encapsulating the molecular machinery required for executing the central 
dogma as well as a metabolism. One defining feature of eukaryotes is that they have an 
additional internal lipid compartment, the nucleus, encapsulating their DNA. This is 
distinct from Archaea and Bacteria, and for this reason and others, these two domains 
have often been grouped together as prokaryotes.9 In the following, we will be primarily 
concerned with common features and will only distinguish between eukaryotes and 
bacteria, disregarding the interesting but less studied Archaea. In bacteria, the entire 
genomic sequence is usually a single circular dsDNA condensed in one area of the cell. 
For E. coli, the size of this molecule is 4.6 Mb (million base pairs). In addition, bacteria 
often have smaller auxiliary pieces of dsDNA called plasmids. These are smaller circular 
molecules that can be replicated independently and transferred between different 
bacteria and thus can be used to transfer genetic traits such as antibiotic resistance. This 
is at the heart of molecular cloning and biotechnology. By inserting a gene of interest in 
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a plasmid and ‘transfecting’ it into a bacterium, the gene will then be replicated as the 
cell divides.10 This technique is made possible by the use of restriction endonucleases 
which are a class of enzymes that cleave DNA at specific sequences.11 Type II endonucle-
ases typically cleave both strands of palindromic sequences, meaning sequences that 
read the same backward and forward. In the context of DNA, this is understood in the 
way that the sequence that reads 5’ to 3’ on one strand reads the same in the 5’ to 3’ 
direction on the complementary strand. By convention, genetic sequences are written 5’ 
to 3’. For example, the restriction endonuclease EcoRI recognizes the sequence 5’-G · 
AATTC-3’ and cleaves the backbone of both the written strand and the identical 
complementary strand (between the G and A). This creates a duplex with a short 
overhang (4 bases, in this case) called a sticky end. If a genetic sequence is cut from a 
genome with a certain restriction enzyme and mixed with purified plasmids cut with the 
same enzyme, the sticky ends will be complementary and can bridge the cut plasmid by 
hybridizing sticky ends to sticky ends. Endonucleases typically hydrolyze the oxygen-
phosphorus bond on the 5’ side of the phosphorus, meaning that the 3’ end of the 
product will have a hydroxyl group and the 5’ end will terminate at the phosphate 
group. This configuration allows for ligase enzyme to covalently ligate the backbone 
once the sticky ends have annealed. Since ligation is an addition reaction between the 
phosphate and hydroxyl group it can be prevented by removing the phosphate on the 5’ 
end with phosphatase enzyme. Enzyme mediated ligation can be an important tool in 
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DNA nanotechnology as the nicks found in oligonucleotide based structures can be 
ligated following annealing based assembly, creating  a sturdier structure.12 
Eukaryotic cells have larger genomes than bacteria, from tens of millions of base 
pairs (bp) to more than 100 billion bp, distributed on several different DNA molecules 
termed chromosomes.13, 14 These extremely long DNA molecules are organized on 
several different hierarchical levels during the cell cycle with the most compacted form 
visible through light microscopy during S phase as irregular X shapes. The first step of 
organization is achieved by spooling DNA onto alkaline proteins called histones. This 
creates a unit called a ‘nucleosome’ containing 146 bp that is visible in electron 
microscopy as beads on a string.15 Compaction of DNA by histones plays an important 
role in regulating gene expression as more compact DNA are less available for RNA 
polymerases to bind. Another level of transcriptional control observed in some 
vertebrates – but not all eukaryotes – is based on methylation of cytosine on carbon 5. 
This chemical modification of DNA generally serves to repress genetic expression. Both 
histone-mediated compaction and methylation can change during a cell’s life cycle but 
can also be passed on through several generations. Thus, the effective genetic expression 
is altered without altering the underlying DNA sequence.16 
2.2 DNA Replication 
The most important biological aspect of DNA’s structure is arguably the ability 
to accurately transmit genetic information to offspring. As noted by Watson and Crick in 
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their seminal paper from 1953, the double-helical structure immediately suggests a 
mechanism for DNA replication. This mechanism is based on a semiconservative 
scheme where unwinding of the double helix allows each single strand to function as a 
template for the synthesis of new strands. Completion of a round of replication thus 
results in two helices, each containing one strand carried over from the parent duplex 
and one newly synthesized strand. If we consider this scheme, we can identify three 
processes that need to occur. The duplex needs to unwind. The resulting supercoil needs 
to be alleviated. And finally, new strands need to be synthesized using the parent 
strands as templates. Each of these processes is catalyzed by a different group of 
enzymes.  
 
Figure 1 - DNA replication. DNA polymerase enzymes processively synthesizes a new 
DNA strand template by the nucleotide sequence in the parent strand. 
In bacterial cells, replication is initiated at a specific site on the genome called the 
origin. Starting at this site, helicase enzymes utilize stored chemical energy by 
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hydrolyzing adenosine triphosphate (ATP) in order to peel the complementary DNA 
strands apart, while single-strand DNA-binding proteins bind the single strands and 
help prevent reannealing. The “bubble” created within the double-helix has two 
junctions called replication forks, and helicases run processively along the DNA in both 
directions extending the loop.17 In both circular prokaryotic and large eukaryotic 
genomes, this process results in supercoiling which is alleviated by topoisomerase 
enzymes. In both prokaryotes and eukaryotes, topoisomerase enzymes are divided into 
type I and type II. Type I works by cleaving just one of the two strands creating what is 
called a nick in the backbone (a single-strand break). This is accomplished by a 
nucleophilic attack from a tyrosine hydroxyl group on a phosphorus atom in the sugar-
phosphate backbone creating a transient covalent bond between enzyme and DNA. 
With the backbone nicked, either the duplex can now perform a controlled rotation or 
the intact single strand can be passed through the nick depending on the enzyme. Type 
II topoisomerases cleave both DNA strands of a duplex using two tyrosine residues. By 
holding the ends in place, a different part of the duplex is allowed to pass through the 
break, thus releasing or introducing supercoil. This reaction cycle is completed with ATP 
hydrolysis.18 DNA polymerases are the primary enzymes responsible for DNA 
replication. These enzymes only catalyze the addition of deoxynucleoside triphosphates 
(dNTP) to the 3’ end of a growing strand using exposed single strand as a template for 
dNTP selection. This has two implications. The first is that a short primer strand is 
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needed for a DNA polymerase to work. A primer is synthesized by a primase enzyme 
and consists of RNA which is later excised and replaced with DNA. The second 
implication is that DNA polymerase only works in the 5’ to 3’ direction as the 3’ group 
makes a nucleophilic attack on the α-phosphate of the incoming dNTP. This results in a 
semi-discontinuous replication scheme where the two strands are replicated in different 
ways. One strand, called the leading strand, is initiated with one primer and extends 
continuously as the parent duplex is unwound. The other strand, called the lagging 
strand, can only be synthesized in short fragments as the synthesis is in the opposite 
direction of the moving replication fork. These short fragments are called Okazaki 
fragments and are 1,000–2,000 nucleotides long in E. coli and 100–200 fragments long in 
eukaryotes.19 Besides catalyzing addition of dNTPs, all DNA polymerases in E. coli also 
have 3’ to 5’ exonuclease activity meaning that they can excise nucleotides in this 
direction. This is done when a noncomplementary nucleotide is erroneously added to 
the growing chain, thus improving the fidelity with which replication occurs. In E. coli, 
the specific polymerase responsible for substituting the RNA primers with DNA is 
called polymerase I. This enzyme also contains 5’→ 3’  exonuclease activity enabling it to 
extend from a nick by excising nucleotides on the 5’ side as it moves along. It can 
thereby remove the RNA primers, and subsequently, ligase can covalently link the 
fragments. 
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The incredible processivity of polymerases has great potential in DNA based  
nanotechnology as these enzymes can function as molecular motors running on DNA 
tracks and even moving loads around.20 
2.3 Polymerase Chain Reaction 
A synthetic form of DNA replication that has been of paramount importance is 
the polymerase chain reaction (PCR) technique. This method reliably amplifies 
miniscule amounts of DNA in a test tube within hours. This is accomplished by using a 
heat-stable polymerase and adding a large excess of both forward and reverse primers 
to a DNA target. Cycling between melting the duplex DNA, annealing primers, and 
letting the polymerase extend results in an exponential replication of the sequence 
bordered by the primers. See Figure 2.21  
In the first step, a mixture of target DNA, nucleotides, primers, and heat-stable 
polymerase is heated to 94 °C in order to melt the target duplex. Heat-stable polymerase 
– such as Taq polymerase from the bacterium Thermus aquaticus – prevents the enzyme 
from denaturing during this step. (2)  In the second step, the temperature is lowered to 
allow the primers to anneal to the target single-stranded DNA. The forward primer 
anneals to the 3’ end of the template strand and the reverse primer anneals to the 30 end 
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of the complementary strand. 
 
Figure 2 - Polymerase chain reaction. In each cycle the duplex is melted and then short 
oligonucleotide primers are annealed. The primers are then extended to form new 
duplexes and the cycle repeated. 
 The temperature chosen may depend on the melting temperature of the primers 
but will typically be around 55 °C. The high concentration of primers prevents the target 
DNA from reforming a duplex. (3) In the third step, the temperature is raised to the 
optimum working temperature of the polymerase. For Taq, this is 72 °C. The polymerase 
then extends the primers in the 5’ to 3’ direction. The first round of replication results in 
the new strands that extend beyond the region bordered by the primers in the 5’ 
direction. Subsequent rounds of replication from newly synthesized strands generate a 
sequence defined by primer location. 
 14 
2.4 Transcription and Translation 
Transcription is the process of synthesizing messenger RNA (mRNA) molecules 
based on the sequence of genes on a DNA molecule. Analogous to DNA replication, this 
is accomplished by an RNA polymerase that reads the template sequence in the 3’ to 5’ 
direction and synthesizes an mRNA molecule in the 5’ to 3’ direction. One of the sharp 
differences between prokaryotes and eukaryotes is the fact that there is only one known 
RNA polymerase in prokaryotes but three distinct RNA polymerases are known in 
eukaryotes.22 This is mirrored in the fact that eukaryotes have more complex RNA-
mediated control of expression. In E. coli, RNA polymerase associates with transcription 
factor proteins to initiate transcription of a gene. For this to occur, the transcription 
complex recognizes a specific sequence by binding non-covalently to the individual 
nucleobases. Both strands in a genome contain genetic information. In the context of a 
specific gene, the strand that is being ‘read’ by the polymerase – the complementary 
strand – is called the noncoding strand or the antisense strand. The strand that is 
identical in sequence to the resulting mRNA is called the coding strand or the sense 
strand.  
Transcription is terminated when reaching a specific sequence, sometimes 
through the association of additional protein factors. The mRNA is processed by 
ribosomes where amino acids linked to transfer RNAs (tRNA) complementary to 
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specific codons (nucleotide triplets) are transferred to a growing polypeptide chain. The 
final product is a protein specified by the original gene sequence in the DNA molecule.23 
The ribosome in itself represents one of the most intricate and fascinating 
examples of nanoscale robotics and has inspired the design of DNA nanostructures that 
can perform controlled polymeric assembly encoded by a DNA template.24, 25 
2.5 Genetic Recombination 
As the information carrier of life, DNA need not only facilitate accurate transmission of 
information but also allow for genetic diversity, the substrate of evolution. One process 
attributing to this is homologous recombination which is the recombination of two 
different DNA duplexes with a stretch of identical sequence. In other words, two 
different DNA duplexes exchanged their binding partners and then they are cleaved and 
the pieces recombined.26 Different organisms have different enzymatic pathways 
facilitating this process but one common feature is the formation of a Holliday junction.27 
Figure 3. This four-arm junction illustrates the topological diversity of DNA that makes 
it suitable not only as a carrier of information but also as a nanometer-scale building 
material.  
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3. Nanotechnological Properties of DNA 
3.1 DNA Tiles 
The birth of structural DNA-nanotechnology dates back to a paper by N. C. 
Seeman published in 1982.28 In this paper Seeman accounts for the construction of 
immobile DNA junctions and envisions how such molecular assemblies might form 2- 
and 3-dimensinal networks through sticky-end ligation.  He imagined such networks 
might facilitate X-ray diffraction of both proteins and the junctions themselves. Part of 
his inspiration for this came from the Holliday junction motif. However, due to the 
sequence similarity between strands in a Holliday junction, a single junction unit – or 
tile – would be immobile. In other words, the junction point would move, eventually 
resulting in two separate duplexes. See Figure 3. Required for solving this issue were 
oligonucleotides appropriately complementary without having sequence symmetry. 
 
Figure 3 - Two different Illustrations of the same Holliday Junction motif. The 
junction can move due to sequence symmetry. Reproduced with permission.28 
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This was realized a year later when Seeman’s research group reported the 
construction of the first immobile 4-arm junction29 and Seeman and colleagues 
subsequently assembled both 5-, 6-, 8- and 12-arm junctions.30, 31 
Aiming at using these components as building blocks for larger aggregates 
double crossover DNA tiles of various compositions has been developed with increased 
rigidity.32 Figure 4. 
 
Figure 4 DNA tiles. (a) Different types of double crossover tiles. The complexes are 
made up of two helices that cross over at two positions. The first distinction between 
the different types is made based on parallel or anti parallel arrangement of the two 
helices. The second distinction is made based on whether there is an even or uneven 
number of half turns between the crossover positions. The third and final distinction 
is for parallel assemblies with an uneven number of half turns between crossovers, 
the last half turn can be either a wide or a narrow groove. The different 
configurations have different symmetries designated with arrows. By adding 
overhangs to the corners of these assemblies it was possible to form 2-dimensional 
grids. Reproduced with permission .33 (b) Grid formed from DAE molecules. Scale bar 
is 300 nm. Reproduced with permission .34 (c) Top: model of four-arm junctions. 
Bottom: AFM image of 2-dimensional grid assembled from four-arm junctions. 
Reproduced with permission.35 
(a) (b) (c)
 18 
This rigidity was hypothesized to allow for predictable aggregation (designed 
assembly), experimentally verified by the assembly of the first 2-dimensional DNA 
lattice.34 Several other grids based on different tiles have been developed e.g. Hao Yan et 
al. developed a four-arm tile, based on connected four-way junctions, used to create an 
periodic assembly and template silver nanowires.35 An issue with tile based assemblies 
is that they are periodic and thereby not fully addressable.  In other words you can 
selectively functionalize or modify individual strands within a tile but the introduced 
modification will be repeated throughout the final assembly. This has been 
circumvented by introducing sequential assembly of individual tiles by annealing tiles 
independently and then assembling in arrays at temperatures below the tile melting 
temperature.36 This strategy relies on the low melt temperature of the short single 
stranded “sticky” ends that mediate assembly of individual tiles. The requirement for a 
low melting temperature places a requirement on the length of these segments and 
thereby the number of unique segments that can anneal in one step. In other words it 
forces the introduction of multiple steps for the assembly of larger structures thereby 
lowering yield. 
3.2 DNA Origami 
A DNA-nanotechnological breakthrough was reached in 2006 with a paper by P. 
W. K. Rothemund.37 In it, Rothemund describes the first implementation of the 
technique of DNA-origami, a method that allows for the self-assembly of 2D structures 
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through the use of one single stranded DNA scaffold and hundreds of small staple 
strands used to "staple" the scaffold into a desired shape. The appeal of this technique 
stems from the fact that large fully addressable structures can be assembled with high 
yield and relative ease. 
 
Figure 5 - DNA origami (a) Illustration of assembly principle with multiple short 
oligo strands “stapling” together a long single stranded scaffold. Reproduced with 
permission.38 (b) Physical basis of structure approximation. A duplex is 2 nm wide 
and one turn is taken to be 10.67 bases or 3.6 nm. Reproduced with permission.37 
The first step in making an origami structure is to approximate the desired shape 
by a geometrical arrangement of DNA helices an integer number of turns in lengths. 
These helices are connected with crossovers, i.e. positions where a single strand from 
each helix crosses over to form part of an adjacent helix. Due to the twist of the DNA 
molecule the crossover points have to be spaced an odd number of half turns apart. 
Rothemund tested 1.5 and 2.5-turn spacings and found the spacing of crossovers to 
influence the interhelix gap, with 1.5-turn spacing conferring a gap value close to 1 nm. 
The second step is to raster fold the main scaffold strand in such a way that is passes 
through all the imagined helices. In doing this a second set of scaffold crossovers are 
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formed with the restriction that when progressing in one direction scaffold crossovers 
have to be an odd number of half turns apart. Conversely, when reversing direction the 
scaffold crossovers have to be an even number of half turns apart. Design of structures is 
greatly simplified by the use of programs such as caDNAno and CanDo and it has been 
shown that the construction principle can be expanded into three dimensions with 
different kinds of helix packing.39-42 
 
Figure 6 - Distances within origami structure. To the right is the sequence structure of 
origami with standard crossover. Individual oligo strands are color coded and the 
scaffold strand sequence is black. Red stars illustrate potential closest spaced 5’ 
functional groups added to the oligo strands. With the duplex model and gap distance 
in figure 5 distances α and β are 5.0 and 6.2 nm.  
Each individual oligonucleotide strand in an origami can function as a handle to 
which a chemical functionality can be attached thus allowing the origami structure to 
function as a molecular scaffold or “breadboard”. The smallest scale or the “resolution” 
that one can work with in this case is defined by each individual oligo. Figure 6 
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illustrates this. If a functional group is added to the 5’ end of the oligo and each duplex 
is 2 nm wide with a 1 nm gap in between duplexes and the length of a base pair is 3.6 
nm / 10.67 base pairs then the distance from functional group to the next closest 
functional group is 5.0 to 6.2 nm. This defines the lower limit, or the “resolution” of the 
origami structure when functioning as a molecular scaffold. 
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4. Sensitization of Transforming Growth Factor-β 
Signaling by Multiple Peptides Patterned on DNA 
Nanostructures 
4.1 Transforming Growth Factor β signaling 
The first discovery of TGF-β was made in 1978 by Joseph E. De Larco and George 
J. Todaro .43 They identified a novel component in extracts of murine sarcoma virus-
transformed mouse fibroblasts that induced cell division in monolayers and colony 
formation in soft agar. It quickly became apparent that a similar factor was present in 
extracts from other tumor cells and that it worked in concert with Epidermal Growth 
Factor to transform the morphology and growth characteristics of treated cells. 
Furthermore, it was shown that the factor was a polypeptide and that there was not just 
one but three different isoforms.44-46 Subsequent research has divulged the canonical 
signaling pathway of the three isoforms TGFβ-1, -2 and -3. Homodimers of these 
different isoforms assemble a ternary complex of two type I and two type II receptors 
(TβRI and TβRII respectively). However, TGF-β2 exhibit lower affinity to the receptor 
complex compared with TGF-β1 and TGF-β3 due to a substitution of Arg25 and Arg94 
in these two isoforms to Lys25 and Lys94 in TGF-β2.47, 48 Despite these differences it has 
been believed that assembly of the ternary complex occurs in the same general manner 
with TGF-β first binding to TβRII homodimers and then recruiting TβRI  homodimers.47, 
49 However, more recent findings have indicated that TGF-β2 shows a higher affinity to 
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TβRI suggesting that the mechanism of complex formation might be isoform 
dependent.50 
 
Figure 7 - TGF-β pathway. Homodimer TGF-β binds type II and type I receptors 
(TβRII and TβRI) forming a ternary complex consisting of type II and type I receptor  
dimmers. Phosphorylation of TβRI by TβRII decreases affinity of TβRI  towards 
inhibitor protein FKBP12 and increases affinity towards R-Smads. Association with 
R-Smads results in R-Smad phosphorylation and subsequent complex formation with 
Smad4 and translocation to the nucleus where the complex functions as transcription 
factor in association with other co-factors, -activators and -repressors. Reproduced 
with permission.51 
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Formation of the ternary complex induces cross phosphorylation of TβRI by 
TβRII.52 TβRII Phosphorylates serine and threonines in the GS domain of TGFβ type I 
receptors (TβRI) which increases the binding affinity for Smad2 and Smad3 and 
decreases the affinity for the inhibitory protein FKBP12.53 Additionally Smad2 is 
recruited through interaction with SARA (Smad anchor for receptor activation) which 
binds both Smad2 and TGFβ receptors.54, 55 TβRI then phosphorylates Smad2 and Smad3 
(R-Smads) at a SXS motif located at the C-termini. This induces disassociation from the 
ternary complex and formation of either dimer or trimer complexes with Smad4 in a 2:1 
or 3:1 ratio of  Smad2 or Smad3 to Smad4.56-58 This complex then translocates to the 
nucleus through nuclear pore complexes (NPC).59 Only relatively small molecules of 
about < 30kDa can passively diffuse through NPC’s whereas larger molecules require 
active transport often mediated by transport receptors.60 Smads may be actively shuttled 
across the nuclear membrane through interaction of a nuclear localization sequence 
(NLS) in the N-terminal with NPC proteins .61 Smad4 has also been shown to contain a 
nuclear export sequence (NES) that is blocked following R-Smad association thus 
sequestering Smad4 to the nucleus.62 However, Smad4 is not essential to all TGF-β 
stimulated responses.63 
In the cell nucleus the Smad2/3:Smad4 complex functions as a transcription 
factor.51 All the R-Smad proteins (except a splice variant of Smad2) contain a DNA 
binding β-hairpin that recognizes the motif CAGAC and GC rich sequences.64-66 
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However, this interaction is not strong enough to form a stable complex with DNA and 
so association with DNA binding co-factors and master transcription factors determine 
binding locations in the genome.51, 67 This helps explain the multiple different outcome 
results following TGF-β stimulation in different cell lines at different stages of 
development.68 Further expanding on the intricate response is the fact that TGF-β not 
only functions through the canonical Smad pathway but also affects several other 
signaling pathways including c-Jun N-terminal kinase, rho-like guanosine 
triphosphatase, phosphatidylinositol-3-kinase, mitogen-activated protein kinases and 
TGF-β-activated kinase 1.69, 70  
4.2 Structure of the Ternary Complex 
Assembly of the ternary complex is initiated by binding of TGF-β to its receptors. 
Groppe et al.71 reported a cooperative assembly mechanism for TGF-β3, with the 
cytokine binding to TβRII with a KD of 0.5 μM and to TβRI with a KD of 188 μM but with 
TβRI binding to the preformed complex of TGF-β3 and TβRII with a KD of 0.6 μM. This 
contrasts with Sergei Radaev et al.50 who reported a KD between TGF-β3 and TβRII of 
0.14 μM and a tenfold lower KD between the preformed complex of TGF-β3:TβRII and 
TβRI of 0.014 μM. This secondary dissociation constant is similar to the 0.016 μM 
reported between TGF-β2:TβRII and TβRI in the same study. This represents a large 
increase in affinity compared to 11.2 μM and 22.4 μM reported between TGF-β2 and 
receptor type I and II respectively.  
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Figure 8 - Crystal structure of the TGF-β, TβRI and TβRII ternary complex. Top: 
Ribbon diagram of TGF-β3 assembly labeled with the different subunits. Individual 
TGF-β subunits are labeled TGF-β3A and TGF-β3B.  Two important elements 
mediating assembly are the flexible N-terminus of TβRII (highlighted with diffuse 
green border) which becomes ordered in the ternary complex and the pre-helix 
extension of TβRI (highlighted in red) that docks at the cytokine:TβRII interface. 
Middle: surface representation of TGF-β3. Reproduced with permission .71Bottom: 
Space fill of TGF-β1 assembly with distance measurement in the plane parallel to the 
membrane illustrating the dimensions of assembly (PDB: 2PJY).   
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While crystal structures have not been determined for the TGF-β2 ternary 
complex, structures for the TGF-β1 and TGF-β3 show a common ligand recognition 
mode with the tips of the cytokine dimer binding TβRII, and TβRI binding with a pre-
helix extension against the TβRII:TGF-β3 interface. Figure 8.  
Affinity between TβRII and the 1 and 3 isotype ligand is driven by salt bridges 
between Glu and Asp residues in the receptor and Arg residues in ligand and some 
hydrophobic contacts as well. The interface between TGF-β1 and -β3 and TβRI is 
primarily hydrophobic with a ~10° rotation of the receptor in the TGF-β3 complex 
relative to the TGF-β1 complex resulting in a decrease of buried solvent accessible area 
from 1518 Å2 to 1118 Å2. The contact interface between the two receptor types buries 740 
Å2 of solvent accessible area. Of importance is a prehelix extension in TβRI that forms a 
hydrogen bond between an Arg residue and Asp residue in TβRII. These residues are 
highly conserved across species. Additionally seven residues in a disordered N-terminal 
extension of TβRII become ordered in the ternary complex bind to TβRI through 
hydrophobic interactions. 
4.3 DNA Nanostructures in Cell Culture 
Structural DNA nanotechnology has made great advances in the creation of self-
assembled addressable nano structures by taking advantage of the predictable 
interactions of DNA base pairing.72-74 Especially the method of scaffolded DNA origami, 
which relies on an excess of many short “staple” strands to fold a long, single-stranded 
 28 
scaffold into almost any desired shape, has proven successful as a robust means of 
patterning inorganic, organic and biological molecules with nano-scale precision.75, 76  
 
Figure 9 - Integrity of DNA origami incubated in cell lysate. (a) Triangular or cuboid 
origami was incubated for 1 or 12 hours in mammalian cell lysate and then run a on 
PAGE gel. Little to no degradation is evident from the intensity of the bands. (b) 
Bands were cut out and origami samples extracted and further analyzed for structural 
integrity by AFM. Reproduced with permission.77 
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The biological and biocompatible nature of DNA allows for these versatile 
structures to interface with cellular systems without prohibitive cytotoxicity. Recent 
research has demonstrated that DNA nanostructures enjoy increased resistance to 
enzymatic digestion,78 and they retain their structural integrity for extended periods of 
time in cell lysate as evidenced by the work of Mei et al.77 They investigated the integrity 
of DNA origami structures incubated in cell lysate from a range of different mammalian 
cells. They found little degradation of samples as evidenced by PAGE analysis and by 
AFM of the PAGE bands. See Figure 9. 
 
Figure 10 - Intracellular localization of DNA origami structures following passive 
uptake. Reproduced with permission.79 
Shen et al. analysed intracellular localization and degradation of DNA origami in 
mammalian cells and found that tubular origami structures were taken up by cells and 
co-localized with lysosomes.79 They used cyanine fluorophores that exhibit strong 
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fluorescent emission upon binding to DNA. By pre-incubating tubular origami 
structures with these fluorophores and then treating cells with the fluorophore loaded 
origami they could trace intracellular localization. Figure 10.  Additionally, upon 
degradation of the DNA, the fluorescence emission is greatly reduced and the authors 
observed a 50% decrease in the fluorescence from the fluorophore loaded origami 
structures in the timespan of 24 hours following cellular uptake. 
Aptamer functionalized DNA nanostructures have been found to be active in 
blood plasma80 and resistance to degradation can be further improved by various 
covalent modifications of DNA oligonucleotides.81 The stability of DNA nanostructures 
in biological environments has allowed for their application in the targeting of living 
cells,82, 83 and it has been shown that DNA icosahedra and origami structures can 
function as drug carriers for doxorubicin.84, 85 Both DNA wireframe tetrahedra and 
origami structures have been coated with CpG oligonucleotides and used as potent 
vehicles for immunostimulation.86, 87  One of the advantages of using DNA 
nanostructures is the ease with which they can be modified as illustrated by the creation 
of a tunable, artificial extracellular matrix (ECM) constructed from DNA motifs 
decorated with fibronectin domains.88  
4.5 DNA Nanostructures for TGF-β Sensitization 
Since many cell surface receptors activate through ligand mediated 
oligomerization followed by phosphorylation of intracellular receptor domains, we 
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hypothesized that extracellular DNA nanostructures might confer even greater control 
over cellular behavior through the preclustering and thus activating or sensitizing of cell 
surface receptors. To test this hypothesis, we set out to test preclustering of transforming 
growth factor-β (TGFβ) receptors using multiple copies of a receptor binding peptide 
patterned on DNA nanostructures. TGFβ plays an important role in the feedback control 
system between ECM and cells and, as such, is an attractive target with significant 
implications in tissue engineering.89 
 
Figure 11 - Surface Plasmon Resonance (SPR) graph displaying response of TβRII and 
TβRI surface to TGF-β and TGF-β + peptide. TβRI surface shows no response to TGF-
β with or without peptide. TβRII shows binding to TGF-β but the extend of binding 
is independent of peptide indicating that the peptide binds outside the TGF-β 
binding site. Reproduced with permission.90 
Lingyin Li et al. used phage display to developed a TβRI and TβRII binding 
peptide that binds the extracellular domain outside the ligand binding domain.90 They 
furthermore demonstrated preclustering of TβRI and TβRII by functionalizing a gold 
surface with the peptide and culturing NMuMG cells on it, resulting in increased 
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sensitivity of the cells to TGF-β.91 A major shortcoming of such surface-based systems is 
that although the overall concentration of peptide bound to the surface can be varied, 
the specific nanoscale density or clustering of peptide cannot be known or controlled.  
Here, we control the nanoscale patterning of the TβR binding peptide of Li et al. 
upon DNA origami by sandwiching tetravalent streptavidin molecules between 
biotinylated peptide and biotinylated origami. Figure 12. 
 
Figure 12 - Illustration of peptide patterned nanostructure binding and clustering 
TGF-β receptors and sensitizing cell to TGF-β stimulus. 
Tall rectangular origami of Rothemund’s original design37  (RRO) was modified 
by leaving out 12 centrally located staple strands (strands denoted as: t-1r14f, t-1r18f, t-
1r16f, t-1r20f, t- 1r14e, t1r14f, t-1r16e, t1r16f, t-1r18e, t1r18f, t-1r20e, t1r20f). New strands 
were designed allowing for 5′ modifications to be displayed on one face of the structure, 
and 10 strands were biotinylated creating a central patch of biotin moieties. Figure 13a 
illustrates a schematic of the streptavidin as blue dots located on orange rectangular 
origami, and Figure 13b illustrates a sideview of the nanoassembly.  
 33 
 
Figure 13 - (a) Schematic of the DNA origami RROt with biotin/streptavidin sites 
marked in blue. (b) side schematic of the nanoassembly. (c) Origami structures before 
assembly with streptavidin and peptide. (d) Nanoassembly after spin purification. 
Peptide−streptavidin complex is visible in the center of the origami structure. 
The multivalency of streptavidin results in the potential for up to three peptides 
to be displayed at each origami biotinylation site assuming a 1-to-1 binding between 
biotins on the origami and streptavidin. This assumption is reasonable when we 
consider the geometry of biotinylation sites on the origami compared to the geometry of 
streptavidin. The protein is a tetramer with four biotin binding sites spaced no more 
than 3.8 nm apart (PDB entry 3RY1).92 
On the other hand, the closest spacing of biotin on the modified origami is two 
helices over. With a 2 nm helix diameter and 1 nm interhelix spacing, this results in a 
distance of approximately 5 nm. It is thus unlikely for a streptavidin tetramer to bridge 
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between two origami bound biotins. Therefore it is reasonable to assume that each 
origami biotinylation site will result in the binding of up to three biotinylated peptides. 
Nanoplatforms were assembled stepwise. In order to purify assemblies from excess 
component building blocks, multiple spin-filtration steps were performed using filters 
selected to retain the nanoassemblies but to allow unassembled, individual components 
to flow through. To investigate the structural integrity of the nanoassemblies after spin-
filtration steps, we performed atomic force microscopy (AFM). Figure 13c shows an 
AFM image of the annealed origami containing the modified staple strands and Figure 
13d shows the final nanoassemblies following spin filtration; the peptide−streptavidin 
complex is visible as a centrally located patch on the origami rectangles.  
During activation of the TGFβ pathway, phosphorylation of TβRI exposes a 
Smad protein binding site which results in Smad2 and Smad3 phosphorylation. 
Phosphorylated Smad2/3 forms a complex with Smad4 and are then translocated to the 
nucleus where they act as transcription factors in association with other proteins. 
Initiation of the signaling pathway can thus be monitored by examining the 
translocation of Smad proteins into the nucleus. This is accomplished by staining fixed 
cells with a primary Smad antibody and secondary Fluorescent antibody. Li et al. 
reported that growing NMuMG cells on surfaces presenting TβR-binding peptides 
sensitize the cells by preclustering TβR and causing endogenous TGFβ in the culture 
medium to trigger a signaling event leading to a translocation of the Smad2/3 proteins to 
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the cell nucleus.91 In our initial experiments in which cells were treated with TGFβ and 
peptide-bearing nanoassemblies, we found that endogenous levels of TGFβ in NMuMG 
cell cultures were not sufficient to elicit a detectable response. Titrating TGFβ we also 
found reduced sensitivity in cells compared to that reported by Li et al. with no Smad 
translocation observed using concentrations below 50 pM of added TGFβ.  Figure 14 
shows NMuMG cells treated with four different concentrations of TGF-β. In the first 
panel where the cells have been treated with 50 pM TGF-β the Smad2/4 stain is localized 
throughout the non-regular chaped cell body. This contrasts with the 80 pM treatment 
where we can see the stain localized in the spherical nucleus with a more faint trace of 
stain in the non-spherical cell body. 
 
Figure 14 - NMuMG cells treated with varying concentrations of TGF-β and stained 
for Smad2/4. While translocation is observed clearly at 80 nM no translocation is 
observed at 50 nM concentration. 
50  M TGF-  60  M TGF- 
70  M TGF- 80  M TGF-  
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 This prompted us to add a background level of 40 pM TGFβ along with 
nanoassemblies in order to detect a positive perturbation of the signaling pathway.  
 
Figure 15 - Representative micrographs of NmuMG cells cultured for 18 h and then 
fixed and stained with DAPI and antibody against Smad2/3 (red stain). Top row is a 
control culture with a background level of 40 pM TGFβ added. As can be seen, the red 
stain is diffuse throughout the cell body with no apparent localization in the cell 
nucleus. Similar results are seen in the second and third rows showing controls with 
added peptide at 12 nM and premixed peptide and streptavidin in a 4 to 1 ratio with 
streptavidin at 3 nM. The fourth row from the top shows cells treated with 
nanoassemblies. As can be seen in the Smad2/3 column, this treatment results in 
translocation of Smad2/3 into the nucleus. This mimics the effect observed when cells 
are treated with a high dose (200 pM) of TGFβ, as in the fifth row. 
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Figure 15 shows representative micrographs of NMuMG cells cultured for 18 h 
with or without nanoassemblies. In cells exposed to 40 pM TGFβ, no translocation of the 
Smad proteins to the cell nucleus was observed. This contrasts with cells exposed to 200 
pM TGFβ where the Smad2/3 stain predominantly overlaps with a DAPI stain of the 
nuclear DNA. To test the efficacy of our nanoassemblies, cells were exposed to 300 pM 
nanostructure and 40 pM background TGFβ. This resulted in Smad2/3 translocation into 
the nucleus as evidenced by colocalization of Smad2/3 stain and DAPI DNA stain. 
Controls were also done with streptavidin and peptide premixed before addition to the 
cell culture as well as samples containing peptide alone. The multivalency of 
streptavidin could conceivably lead to limited clustering when the tetrameric protein 
binds up to four biotinylated peptides. However, as the micrographs in Figure 15 show, 
no Smad2/3 translocation is observed when premixed streptavidin and peptide is added 
to the cell culture. Neither of these control conditions activated Smad translocation. 
In order to achieve a quantitative measure of the biological pathway induction, 
we employed a luciferase assay responsive to Smad mediated TβR stimulation. Cells 
were transfected and then exposed to either 200 pM TGFβ or 40 pM TGFβ and 
nanoassemblies. Concluding from Figure 15 that no Smad2/3 translocation takes place 
when treating cells with peptide or streptavidin+peptide, these conditions were 
included as negative controls. Figure 16 shows relative luminescence values. 
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Figure 16 - Luminescence from cell samples treated with 200 pM TGFβ, nanoassembly 
and 40 pM TGFβ, peptide and 40 pM TGFβ, and pep- streptavidin complex and 40 pM 
TGFβ. Error bars represent standard deviation. 
Samples treated with nanoassemblies showed significant activation of the Smad 
pathway compared to the negative control samples treated with peptide alone or 
peptide and streptavidin preincubated. The highest level of pathway activation was seen 
in the positive control sample exposed to 200 pM TGFβ. This indicates that our 
nanoassemblies are sensitizing NMuMG cells to TGFβ. We hypothesize that this occurs 
because preclustering of the receptors by the nanoassemblies results in decreased 
entropic cost compared to the normal pathway where receptor clustering occurs after 
TGFβ binding. It is conceivable that the efficacy of the nanoassembly could be increased 
by replacing the noncovalent biotin-streptavidin linkage with a direct covalent coupling 
between the peptides and the DNA origami. This would also allow for tighter control of 
peptide position and multiplicity than provided by the tetravalent streptavidin. 
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Additionally, a covalent attachment would make it easier to eliminate free peptide in the 
assembly samples which might further improve preclustering of receptors. 
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5. Functionalization of DNA Nanostructures with Zinc 
Finger DNA Binding Peptides 
DNA binding proteins represents an attractive strategy for functionalizing DNA 
nanostructures as fusion constructs of such proteins would be able to add the catalytic 
activity of enzymes or the antigen affinity of antibodies to specific sites on DNA 
nanostructures by binding to select sequences on the nanostructures.  Zinc fingers are 
small protein domains that typically interact with other molecules such as DNA or other 
proteins. Zinc is either necessary for correct folding of the domains or for the specific 
interaction with targets.  
 
Figure 17 - Structure of a six-finger zinc finger peptide bound to DNA. PDB: 2I13 
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The classic DNA-binding zinc finger was first described by Klug and colleagues 
as part of the Xenopus laevis transcription factor TFIIIA.93 It comprises two cysteine 
residues at the N-terminus end and two histidine residues at the C-terminus and is as 
such classified C2H2. These four residues coordinate a zinc atom which is crucial for the 
correct folding of the domain. The N-terminus adopts a β-hairpin conformation. The C-
terminal part of the domain forms an alpha-helix. This helix fits into the major groove of 
duplex DNA and protruding side chains form both nonspecific and sequence specific 
contacts with the DNA molecule. A zinc finger domain can thus recognize a specific 
sequence of 3 to 5 nucleotides. The strength of the motif is that additional domains can 
be added successively in a modular fashion to create a protein which recognizes a longer 
DNA sequence with high specificity and affinity.94 Barbas and colleagues showed that 
up to 6 naturally occurring zinc finger domains in succession can specifically recognize 
18 basepair long sequences both in an eukaryotic genome and in vitro (Figure 17).95 They 
have further developed a library of 16 GXX recognizing domains and shown that they 
can cut and paste these together to target arbitrary 6x(GXX) sequences.96 This potentially 
represents an unexploited avenue for construction and targeting of DNA nano-
structures, as it allows for engineering precise sequence affinity into any desired fusion 
protein construct. 
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5.1 Zinc Finger Constructs 
To test this DNA nanostructure functionalization strategy we expressed three 
different zinc finger constructs of zinc finger domains fused to maltose binding protein 
(MBP). The MBP domain allows for purification using a maltose column and also 
provides a visual cue in AFM. Additionally a Factor Xa cleveage site enables the 
separation of zinc finger and MBP domains. Three different constructs were expressed. 
6F is a 6 finger domain fused to MBP that recognizes the sequence GGG GCC GGA GCC 
GCA GTG (E2C). 2x6F is made up of two 6 finger domains. One domain recognizes the 
same sequence as 6F and the other domain recognizes the sequence 
GACTCCGGCTCCGGCTCC (E3). These two domains are linked with a nine residue 
glycine/serine linker region and fused to a MBP domain. 2x3F has two DNA binding 
domains like 2x6F but only has 3 finger subunits in each DNA binding domain that 
recognizes the sequence GGG GCC GGA. The 6F protein should allow for assessing the 
binding efficiency of the six zinc finger subunit by to DNA nanostructures by 
visualizing the MBP domain with AFM. The rationale for having two separate binding 
subunits in the 2x6F and 2x3F proteins is to use the proteins as orthogonal linkers 
between different DNA nanostructures. This could allow for the assembly of larger 
structures by circumventing the problem of charge repulsion in larger DNA based 
structures while having both a six and three finger based protein would allow for 
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comparison of the efficiency of linking as a function of number of “fingers” in the DNA 
binding domains. 
5.2 TX tile Design and Assembly 
To test assembly of DNA nanostructures by 2x6F we designed a TX tile based 
array with binding sites for the six finger domain. The outer strands of the tile were 
modified with protruding hairpins containing the zinc finger target sequence and two 
pairs of flanking nucleotides. 4 T’s were incorporated to terminate the hairpin loop.  
 
Figure 18 - DNA structure and sequence of a single TX tile with zinc finger binding 
sites. Several tiles anneal by single stranded overhang to form linear arrays. 
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Different target sequences were included in hairpins protruding in the plane on 
either side of the tile. The goal of having two different targets on either side of the arrays 
is to bridge different arrays with proteins consisting of 2 6-finger domains linked with a 
9 residue glycine/serine linker. TX arrays have previously been used to demonstrate 
orthogonal linking using aptamers and anti-aptamer antibodies. However, zinc finger 
proteins have potential to achieve such linking with a higher degree of versatility and 
ease (Figure 19). 
 
Figure 19 - (a) Cartoon illustration of two zinc finger domains (dark red) linked 
together (orange) with a terminal Maltose Binding Protein (MBP) domain (green) 
connecting two different DNA arrays (blue). (b) AFM image from Li et al. showing 
arrays bridged with antibodies and aptamers. Reproduced with permission.97 
Structural integrity of the linear arrays was verified by atomic force microscopy. 
Figure 20 show that linear arrays are formed and appear corrugated in accord with the 
protruding hairpin structure. The line in Figure 20b specifies a cross-section 
measurement indicating that the width of the arrays is approximately 20 nm. This is 
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consistent with the tile design when including the 22 nucleotide side arms but excluding 
any gap between helices. As the spacing between cross-overs are 21 to 31 nucleotides 
apart, comparable to the 32 nm in origami structures, the gap size would be expected to 
be similar. It is likely that the width measurement does not accurately reflect the entire 
width of the structure including side arms as the side arms are not as structurally robust 
as the core tile array. 
 
Figure 20 (a) TX linear arrays on mica. (b) Zoom of the sample from a. 
0  m 3  m 0 nm 340 nm
8 nm(a) (b)
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5.3 Expression and Relative Specificity of Zinc Finger Constructs 
 
Figure 21 Representative Coomassie stained SDS-PAGE gel of 6F construct. The 
theoretical mass of the construct is 65 kDa. Lane 1and 2: 6F construct after maltose 
column affinity purification. Lane 3 and 4: 6F construct after 30 kDa spinfilter 
purification. 
Proteins were expressed in E. Coli and purified by running cell lysate through an 
amylase column and then eluting the protein with a solution of maltose. An additional 
concentration step was done using 30 MWCO spin filters. To assess the purity of the 
samples we performed SDS-PAGE.  Figure 21 indicates that a high degree of purity was 
achieved following elution from the amylase column. To assess the activity of expressed 
proteins enzyme-linked immunosorbent assays (ELISA) were conducted with STV 
coated plates to which biotinylated DNA hairpins were bound and then incubated with 
cell lysate followed by alkaline phosphatase (AP) fused anti-MBP antibodies. AP 
catalyzes the reaction of para-nitrophenylphosphate to para-nitrophenol and the 
concentration of para-nitrophenol can be accurately measured by its absorption at 405 
nm.  
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Figure 22 - ELISA analysis of zinc finger binding. Fresh cell lysate is diluted along the 
z-axis. Different series correspond to different DNA targets as specified in 
experimental methods section. Background is done without a biotinylated DNA 
target. 
Figure 22 shows ELISA results. All three constructs were tested. The z axis 
represents a serial dilution of centrifuge clarified lysate of E. coli cells containing the 
relevant plasmid. Different series represent different DNA targets as specified in the 
right margin. The non-target sequence is of the form (GXX)6. As such it would be 
expected to show a higher affinity for the proteins than a random sequence. At higher 
dilutions we see specific binding to the target sequence and little difference between 
background and nontarget. 
5.4 DNA Nanostructure and Protein Association 
Association between protein and TX linear arrays were investigated with AFM. 
Several different buffer schemes were tested including: 1) Adding protein in zinc buffer 
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A (ZBA) to TX arrays in TAEM buffer. 2) Adding protein in ZBA to TX arrays in 
ZBA(Mg) buffer. 3) Adding ZnCl2 to premade TX arrays in TAEM buffer for final ZnCl2 
concentration of 90 μM and then adding protein in ZBA. The initial experiments were 
done with 2x6F proteins on mica. Proteins appear as approximately 1 nm protrusions. 
This is smaller than the approximate 6x4x2 nm dimensions of MBP and could be due to 
partial denaturation of the protein on the mica surface.  Figure 23 shows AFM 
micrographs of TX arrays annealed in TAEM with added ZnCl2 incubated with 6F 
proteins constructs. No apparent binding of protein to the TX arrays is visible. 
 
Figure 23 - AFM of TX arrays in TAEM buffer with 90 μM ZnCl2 incubated with 6F 
peptide.  
The fact that no binding was observed between TX arrays and zinc finger 
proteins when assayed with AFM, but binding was observed using the ELISA assay, led 
us to believe that it might be the interaction with the mica surface that impeded binding 
between the duplex binding site and the zinc fingers. This prompted us to change the 
8 nm
0  m 2  m 0  m 0.5  m
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nanostructure motif. Using a rectangular origami instead of TX arrays would allow for a 
“vertical” binding site protruding away from the surface. It could be that the TX design 
impedes binding of the zinc finger because the binding site is “horizontal”, which means 
it binds to the mica surface. Perhaps this “pushes” bound protein off the duplex or 
arrays with protein bound don’t bind to the mica surface very well resulting in no 
imaging of them. 
 
Figure 24 Origami and 6F zinc finger proteins. (a) Illustration of origami structure 
with “vertical” binding site. (b) Origami structures annealed in TAEM buffer and 
spin filtered with ZBA. Structures retain structural integrity in ZBA buffer. (c) 5 nM 
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6F protein incubated on mica. (d) Origami sample spinfiltered with ZBA and 
incubated with 47 nM 6F half an hour before imaging.  
Figure 24 illustrates origami design for detection of 6F binding as well as AFM 
results. A single staple strand was modified with a hairpin protrusion containing the 6F 
binding site. Figure 24b-d illustrates origami structure annealed in TAEM buffer and 
then spin-filtered with ZBA exchanging the buffer, 6F protein by itself at 5 nm and 
origami sample incubated with the protein. The high degree of binding to the surface at 
a low protein concentration of just 5 nM illustrates an issue with the AFM approach. 
With a reported KD of 5-10 nM for the six finger zinc finger binding motif we would 
ideally like to use protein concentrations in the micromolar range for a high degree of 
bound target sites. However, this makes it impossible to visualize binding in the AFM. 
Two different approaches could help alleviate this problem. One is to alter the mica 
surface so as to prevent non-specific deposition of protein on the surface. Another is to 
try and bind the protein to the nanostructure at sufficient concentration and then purify 
the nanostructure with bound protein. This is dependent on a reasonably slow off rate 
for the protein to remain bound during and after purification. 
5.5 Zinc Finger Study by Nakata et al. 
Nakata et al. reported on zinc finger proteins binding to a modified origami 
structure.98 They used the zinc finger motifs zif268 and AZP4 and an origami structure 
with cavities containing multiple binding sites. Figure 25a shows the origami design 
with a four hairpins localized in a central cavity with each hairpin containing a zinc 
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finger binding site. They mixed this structure with 250 nM biotinylated zinc finger 
protein and 250 nM streptavidin. Then they imaged the sample using AFM as seen in 
Figure 25b. It can be seen that they observe much less non specific binding to the surface 
that we have observed. This could be caused by their use of a smaller zinc finger 
construct without the MBP domain. However, they also express a fusion construct with 
a fluorescent Cerulean domain of 27 kDa that likewise does not seem to cause 
substantial nonspecific surface binding.  
 
Figure 25 - Zinc finger binding to origami by Nakata et al. (a) Schematic illustration 
of the origami structure employed to bind zinc finger proteins. The four red hairpins 
in the center cavity contain binding sites. (b) AFM of origami bound to biotin tagged 
zinc finger protein bound to streptavidin. Scale bar = 100 nm (c) Fluorophore tagged 
zinc finger proteins incubated with origami. Lane 1: origami with no binding sites 
incubated with zif268. The fluorescent protein does not travel into the gel. Lane 2: 
Origami with binding site incubated with zif268. A red band is visible from both the 
origami and the excess staple strands both of which contain binding sites. Lane 3: 
Origami with binding site incubated with AZP4. Lane 4: Origami with both binding 
sites incubated with both AZP4 and zif268. Orange color indicate that both the red 
and green fluorescently tagged zif268 and AZP4 co-migrate with the origami band. 
Reproduced with permission.98 
(a) (b)
(c)
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The authors only show one AFM micrograph with bound zinc fingers in the 
central cavity of a couple of origami structures. They also couple a fluorophore the zinc 
fingers and incubate with each construct with its respective origami before running the 
samples on a gel. Figure 25. No migration is seen of the fluorescent proteins when 
incubated with an origami without binding sites (Lane 1 Figure 25c) but when incubated 
with origami containing the relevant binding sites fluorescent bands co-localize with the 
origami and staple strand bands. 
 A clear difference in their approach is the use of four binding sites located in a 
cavity. The presence of four sites should greatly increase the total affinity between 
structure and protein but it also lowers the “resolution” of the functionalization 
technique in the sense that a larger area is needed. In other words, instead of knowing 
exactly which DNA strand in the structure is functionalized you have four strands 
covering a larger area where any one or more these strands could be bound to a zinc 
finger construct.  
5.6 Conclusion 
DNA binding proteins are an attractive means of adding protein functionality to 
DNA nanostructures. However, nanostructures typically don’t function in the high 
concentration, dynamic context of the intracellular space. Hence binding affinity and off 
rates becomes very important for assembling durable and lasting structures. We have 
expressed zinc finger constructs that successfully bind their duplex targets in an ELISA 
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assay. However, investigation of binding to modified nanostructures by AFM is 
impeded by the high degree of non-specific surface binding. 
The successful demonstration by Nakata et al. comes at the cost of “resolution” by 
requiring multiple binding sites on the nanostructure. This is of crucial importance since 
the potential scientific benefits of self-assembled DNA nanostructures is dependent on 
the spatial control of structures to within a few nanometers. Additionally the 
underdetermined nature of multiple binding sites makes other techniques 
comparatively more attractive such as biotin-streptavidin based methodologies. 
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6. Functionalization and Modification of DNA 
Nanostructures with Peptide Nucleic Acid 
6.1 Functionalization of DNA Nanostructures. 
6.1.1 Introduction 
During the last two decades, nucleic acids have emerged as a promising material 
for nanotechnology due to the highly predictable and programmable Watson-Crick 
hybridization of complementary nucleic acid sequences.72 The high fidelity and 
hybridization allows the formation of diverse structures through sequence design.99 Of 
particular success has been an approach known as DNA origami in which a single-
stranded scaffold if folded via a large number of short synthetic strands.37, 76, 100 Current 
synthetic methods for producing natural and artificial nucleic acids with specific 
chemical modifications allow the access to milligrams of material, which is adequate for 
fundamental studies and practical applications.101. The easy control of the geometry, 
diverse range of shapes, and high resolution of the nucleic acid structures has in recent 
years lead to an expansion of the field into the broader domain of biomaterials finding 
use in both tissue culture,88, 102 drug delivery84, 85 and immunotechnology.86, 87, 103 
Crucial for the practical use of these structures is a convenient way  to 
functionalize specific locations. Several research groups have explored various means of 
functionalization. A commen approach relies on incorporating DNA oligos that have 
been chemically modified with solid phase phosphoramidite chemistry during 
synthesis. For example incorporation of oligos with terminal thiol groups allows binding 
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to gold nanoparticles (AuNP). Due to their electronic, optical and magnetic properties, 
AuNPs have been extensively incorporated into different nano structures formed from 
thiol-modified DNAs.38, 104-108 DNA oligos modified with terminal amines or click-
chemistry partners allows for chemical modification of resulting nanostructures with 
NHS-esters and trough click chemistry.109 Enzymatic modifications of DNA 
oligonucleotides with terminal transferase allows for addition of deoxynucleotides to the 
3’ end of one oligonucleotide or to several different ones in parallel. In addition, the 
appended deoxynucleotide can carry a wide variety of chemical groups that are thus 
displayed on the final assembled nanostructure.110 As opposed to termini modification of 
DNA oligos, internal purines can be sequence specifically alkylated using 
pyrrole−imidazole (PI) polyamide enabling modification with functional groups such as 
biotin.111 See Figure 26. 
 
Figure 26 - Illustration of pyrrole−imidazole polyamide mediated sequence specific 
functionalization of double helices in a DNA Nanostructure. Reproduced with 
permission.111 
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PI polyamides are capable of sequence specific binding to the minor grove of the 
double helix.112 By functionalizing a PI polyamide with 1-(chloromethyl)-5- hydroxy-1,2-
dihydro-3H-benz[e]indole , Sugiyama and colleagues were able to covalently bind to the 
N2 position on a adenine adjacent to a specific six nucleotide sequence incorporated in a 
DNA nanostructure. Additional functionalization with biotin enabled visualization and 
analysis of the modification using AFM. 
Proteins naturally have a great range of functionalities and catalytic activities 
and also share buffer compatibility with DNA. As such they are extremely desirable 
components to incorporate in DNA nanostructures. Previously it has been shown that 
incorporation of an antigen allows for programmed patterning of antibodies on DNA 
nanostructures.113 A simpler approach utilized the ligand recognition of aptamers to 
attach thrombin and platelet derived growth factor (PDGF) to DNA nanostructures. 114  
 
Figure 27 - Illustration and AFM image showing PDGF bound to aptamer 
functionalized DNA origami structure. Illustration on the left show rectangular DNA 
origami with red aptamers binding yellow PDGF proteins and blue control strands 
not binding PDGF. The insert in the middle AFM image delineates the height trace 
shown to the right. Reproduced with permission.114  
 57 
Yan and colleagues incorporated PDGF and thrombin binding aptamers in DNA 
origami structures and showed specific binding of the ligands resulting in two-
dimensional multiprotein nanoarrays. See Figure 27. The same thiol modification of 
DNA oligonucleotides used to link AuNPs to DNA was used to make maleimide-based 
modifications of the DNA structures. For example, a maleimide-linked nitrilotriacetic 
acid (NTA) was coupled to a thiol group; Ni2+ binding to NTA in turn allowed the 
binding of his-tagged proteins to the Ni2+-NTA complex.115 Thiols can also be used for 
covalent coupling to amine groups using maleimide-N-hydroxysuccinimide 
heterobifunctional linkers.116 The N-hydroxysuccinimide reactive group has been used to 
incorporate snap- and halo-tags allowing for covalent incorporation of fusion proteins 
into DNA nanostructures.117, 118 Heterobifunctional linkers based on this reactive group 
have also been used to link cytochrome c covalently to oligonucleotides allowing for self 
assembly of a DNA tetrahedra around the protein.119 Distefano and colleagues similarly 
encapsulated green fluorescent protein (GFP) in a DNA tetrahedral but relied on 
addition of an azide-modified isoprenoid diphosphate to a C-terminal peptide tag on 
GFP using protein farnesyltransferase (PFTase). Following this step GFP is coupled to an 
alkyne modified DNA oligo and through the Huisgen cycloaddition (“click”) reaction.120 
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Figure 28 - Gold binding peptide incorporated in DNA nanostructure. (a) Peptide 
WALRRSIRRQSY (b) AFM of two dimensional array functionalized with peptide on 
opposing sides. Bound AuNP’s favor one side. (c) Map of array illustrating peptides 
displayed on opposing sides of array as blue and red circles. Reproduced with 
permission.121 
Illustrating the diverse functionality of peptides is the in vitro evolution of 
peptides for recognition of inorganic material.122 LaBean and colleagues used DMTMM 
to link the C-terminal of the gold binding peptide WALRRSIRRQSY to oligonucleotides. 
These could then be incorporated in a tile based two-dimensional array and subsequent 
addition of AuNP’s showed preferential binding to peptides without the use of thiol 
chemistry.121 See Figure 28. 
6.1.2 Peptide Nucleic Acid 
Recently attention has been directed toward using peptide nucleic acids (PNA) 
for extending the chemical versatility of DNA nanostructure. PNA is a synthetic DNA 
analog consisting of  a backbone of repeating N-(2-aminoethyl)-glycine units to which 
purine and pyrimidine bases are linked by amide bonds.123 See Figure 29.  
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Figure 29 - Illustration of PNA structure compared to peptide and DNA structure. The 
amide bond common to PNA and peptide backbone is boxed in. PNA sequences are 
written from N to C terminal by convention and preferentially binds to DNA in the 
anti-parallel orientation illustrated here. Reproduced with permission.124 
The neutral backbone affords PNA characteristics different from those of DNA, 
such as increased affinity towards complementary strands at low salt concentrations.125 
Since PNA is synthesized by the same solid phase chemistry as peptides, it is simple to 
make PNA-peptide chimeras and consequently to incorporate peptides at well-defined 
locations in DNA nanostructures.126  
Hao Yan and colleagues used a three dimensional DNA nanocage to bind to bind 
PNA-peptide chimeric molecules that were also functionalized with dyes allowing 
enabling them to assay binding in the nanocage. See Figure 30. Although their peptide 
sequences where only three residues long, this project illustrates the potential for using 
the highly predictable nature of DNA folding to overcome the difficulty in predicting 
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peptide folding. The ability to orient catalytic peptides in three dimensional space could 
open up for the design of novel biological catalysts. 
 
Figure 30 - Illustration of PNA-peptide chimera binding in a DNA nanocage. 
Incorporation of a dye allows for tracking the binding of two different PNA-peptide 
chimeras. Reproduced with permission.126 
The unique properties of PNA can also be used to construct nanostructures with 
different handedness than that of DNADNA duplexes127 and with low tolerance of base 
mismatches useful in detection systems.128, 129 One of the most interesting features of 
PNA molecules is that their high affinity for complementary DNA allows for sequence 
specific invasion of DNA duplexes.123, 130, 131 This property can be used to create nanoscale 
assemblies using double stranded DNA as a scaffold132, 133 or as a way to manipulate 
dynamic nanostructures by addition of PNA without the use of predesigned toeholds.134, 
135 PNA holds promise for greatly expanding of the toolbox of DNA nanotechnology 
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both by introducing chemical reactivity in the form of peptides and by aiding in the fine 
tuning of nanostructure designs. 
6.2 Experimental Design 
 
Figure 31 – Illustration of RROb. Three different PNA binding sites on the DNA 
origami structure have been designed to investigate inclusion of PNAb. Orange 
cylinders represent the DNA duplex forming the structure. Yellow cylinders represent 
single stranded regions complementary to PNA. The binding site in the front of the 
picture that is “inline” with the orange duplex cylinders are located on the m13 
scaffold. Notice that this model is not to scale nor does it accurately depict no. of 
bases. However, it is meant to better convey the location and the conformation of 
binding sites. 
We have investigated the incorporation of PNA in DNA nanostructures using a 
16-base PNA molecule with three lysines (Lys) at the C end (PNAb). See Figure 32. The 
lysines’ sidegroup has a pKa of 10.5; hence at pH 8.00 each PNA strand has three positive 
charges. We also included a biotin group at the N end of the PNA. To test the 
incorporation of this PNA molecule into DNA structures, we employed a two 
dimensional DNA origami structure of Rothemunds original design herein labelled RRO 
(regular rectangular origami) following previous convention.37 We modified RRO to 
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include three PNA binding sites at the locations and with the configurations identified 
in Figure 31 giving the structure names RROb. 
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Figure 32 PNAb structure and sequence. 
We labeled the binding sites centre, side and corner. The side site consists of a 
stretch of exposed, uncomplemented M13 scaffold strand along the edge of the 
rectangular structure complementary to the PNA sequence. The centre site is placed in 
the centre of the two dimensional origami and consists of overhangs from two staple 
strands forming a V-shaped binding site; each overhang is complementary to half of the 
PNA molecule. The corner site is located at the corner and consists of an overhang from 
a staple strand and has a sequence fully complementary to that of the PNA molecule. 
The attachment of the PNA to these sites was assayed using streptavidin (STV), which 
can bind with high affinity to biotin.  
The increased stability of a hetero DNAPNA duplex when compared to a 
DNADNA duplex allows PNA to invade a DNA duplex. This invasion represents a 
method for DNA modification that is orthogonal to the widely used toehold-mediated 
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strand displacement for the introduction of controlled dynamic behavior in nano 
devices.5 However, the relative stability of the DNAPNA and DNADNA duplexes is 
highly dependent on ionic strength. Hence we decided to first evaluate the kinetics of 
invasion of a DNA duplex by the PNA molecule and its dependence on salt 
concentration. We employed the method of initial rates and a DNA duplex labeled with 
a fluorophore and a quencher to monitor by fluorescence the dissociation of the DNA 
duplex in the presence of PNA. Building on knowledge learned from this kinetic 
experiment, we designed a linear TX array136, 137 to display invasion sites in order to 
visualize invasion of the biotinylated PNA strand. See Figure 33. 
 
Figure 33 - (a) TX tile fully illustrated with sequences. The top protruding duplex 
allows for invasion of complementary PNA strand. (b) Multiple tiles assemble into 
linear arrays. In this illustration four tiles are linked togehter. This enables estimation 
of the efficiency of PNA invasion when using biotinylated PNA as the bound 
streptavidin can be counted in AFM. STV is illustrated here as yellow circles at the 
first and last tile in a four tile array. 
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6.3 Results and Discussion 
6.3.1 Melting Curves 
The melting curves were measured to evaluate thermodynamic stability of a 
DNAPNA duplex compared to a DNADNA duplex. The enhanced thermal stability of 
the DNAPNA duplexes over the DNADNA duplexes were observed in solutions of 
different salt concentrations. The melting temperatures Tm of PNADNA duplex under 
different salt concentrations are above 75 °C in all cases, which is much higher (by 19-38 
°C) than that of the DNADNA duplex (Table 1). The melting temperatures of this 16-bp 
duplexes are in agreement with the literature values of 15-bp duplexes.138 Representative 
melting curves are shown in Figure 34.  
Table 1 Melting temperatures (˚C) of DNADNA and DNAPNA duplexes in 1X TAE 
buffer at 3 μM and different concentration of MgCl2. PNA sequence: 
TGAATATAGTTGGGA. Complementary DNA sequence: TCCCAACTATATTCAT 
Conc. Of MgCl2 DNA:DNA PNA:DNA ΔTm 
1 40 78 38 
6 56 77 21 
12.5 57 76 19 
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Figure 34 - Melting curves of PNADNA (solid line) or DNADNA (dotted line) 
duplex in 1, 6 or 12.5 mM MgCl2. Strands were at a concentration of 3 μM. 
The melting curve of DNADNA duplex has a slightly sharper transition around 
the melting temperature of duplex than the PNADNA duplex, which demonstrated a 
higher cooperativity of the base pairs in DNADNA duplex than that of the PNADNA 
duplexes.  However, the melting curves of PNADNA shifted significantly to higher 
temperature, indicating the great thermodynamic driving force of the strand invasion of 
PNA in DNA nanostructures. When the salt concentration decreases from 12.5 to 1 mM, 
the thermal stability of PNADNA decreases while that of DNADNA increases, leading 
to a higher thermodynamic driving force of strand invasion at lower salt concentration. 
The same result is further observed in the fluorescence assay of duplex invasion under 
different salt concentration. 
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6.3.2 Binding of PNA to DNA Nanostructures 
 
Figure 35 - Binding of PNA or DNA to RRO was evaluated by counting STV at 
different locations. Each micrograph was treated individually the mean displayed 
with error bars representing standard deviation. 
To evaluate the thermodynamics of PNA binding relative to three different 
binding sites on a two dimensional DNA origami we annealed the origami with 
equivalent conc. of biotinylated PNA. Samples were then incubated with 1-2 μM STV for 
1-2 hours and imaged with AFM. Figure 35 a and b shows representative images of 
structures with biotinylated PNA and a control with a biotinylated DNA probe. A total 
of 10 different micrographs were collected and analysed. The number of structures and 
binding events counted are listed in Table 2. For each individual micrograph the binding 
rate was calculated. The mean value is displayed in Figure 36. 
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Table 2 Total number of counted origami structures and bound STV’s at different 
binding sites. 
 PNA DNA 
Origami 596 883 
Center Site 510 5 
Edge Site 322 458 
Corner Site 344 276 
 
 
Figure 36 - Binding of PNA or DNA to RRO was evaluated by counting STV at 
different locations. Each micrograph was treated individually the mean displayed 
with error bars representing standard deviation. 
An oligomer of 16 nucleotides generally does not have high enough affinity to its 
complementary strand to effectively target DNA nanostructures. However, Figure 35a 
shows that our PNA molecule targets the centre site with a high degree of binding and 
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significantly higher than the two other sites. The 16 nucleotide DNA sequence on the 
other hand achieves almost zero binding at the centre site. This is in agreement with 
previous reports of diminished hybridization at the centre of RRO which Jungmann et al. 
ascribed to an increased off rate.139, 140 We ascribe the very low level of binding observed 
here to the combination of location on the origami and conformation of the centre 
binding site. The V-shaped binding conformation was originally introduced by Ke et al. 
to aid in AFM identifying 40 nt long probes,139 but we conclude that this conformation is 
ill suited for shorter probes. It is conceivable that fraying originating at the V vertex can 
quickly expand to full dissociation. Interestingly we do see a higher binding of the DNA 
control probe to the side site compared to the corner site. We ascribe this to the 
additional base stacking at the ends of the DNA probe and believe that including base 
stacking pairs at the ends of probe targets could increase the affinity of future target 
designs. The positive PNA strand shows a higher degree of binding to the corner site 
than the DNA probe but about the same degree of binding to the side site. This is most 
likey due to a disruption at the ends of the PNA molecule resulting from the added 
lysine residues at the C terminal end and the added C10 spacer on the N terminal. The 
biggest difference is observed at the center site where we observe almost no DNA 
binding but 85 percent PNA binding. We believe this is due to an inversion of the 
electrostatic force between the PNA probe and the origami surface compared to the 
DNA probe and the surface. Unlike the corner site that protrudes freely into solution 
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and can thus avoid close contact with other parts of the structure and the side site that 
only sees one neighboring duplex. The center site sits in the middle of the negative 
charged origami and the conformation of the binding site is such that the entirety of the 
probe is brought closer to the origami surface thus increasing the electrostatic force of 
either sign. Johnson-Buck et al. propose that DNA nanostructures enrich the immediate 
surrounding environment in positive counterions at low ionic strength creating a diffuse 
layer of positive counter ions.141 Our present results suggest that this layer is not enough 
to prevent fraying of the DNA probe at the binding site vertex leading to dissociation 
and conversely that the positively charged PNA remain highly attracted to the origami 
surface. 
The charge of the DNA backbone becomes an increasing challenge in large dense 
three dimensional nanostructures requiring slow anneals of up to 178 hours with high 
salt concentration.39, 41 Our results indicate that positive PNA probes of even shorter 
lengths could be used as crucial “anchor” strands enabling even larger structures or 
shorter more convenient anneals. 
6.3.3 Duplex Invasion 
We further wished to investigate the propensity for our positively charged mixed 
base PNA probe to invade a nanostructure embedded DNA duplex. To do this we first 
did a fluorescence assay of the invasion into a fluorophore and quencher labeled single 
duplex. This allowed us to determine the initial rates of the invasion reaction while 
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varying the concentration of both duplex and PNA and thus isolate the exponent in the 
rate equation;                  where [DNA] is the concentration of pre-annealed 
DNA duplex and [PNA] is the concentration of added PNA. Figure 37a shows 
representative graphs of the initial concentration of dissociated duplex following 
addition and mixing of PNA at 1 mM MgCl2.  
 71 
 
Figure 37 - (a) Representative graphs of initial concentration of dissociated duplex 
following mixing with different start concentrations. PNAb is mixed into a solution 
of pre-annealed AGGGTTGATATAAGTA(Iowa Black RT) and 
(Cy5)TACTTATATCAACCCCT. (b) Representative graphs of initial concentrations 
following mixing at different MgCl2 concentrations. 
(a)
(b)
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Table 3 Initial rates of dissociation of duplex DNA following addition of PNAb under 
different initial reactant concentrations and MgCl2 concentrations. 
 Initial rates [µM/sec] R2 of linear fit 
0.5 µM duplex, 1 µM PNAb, 1 µM MgCl2 0.0022 0.9372 
 0.0017 0.9278 
 0.0021 0.9160 
0.5 µM duplex, 2 µM PNAb, 1 µM MgCl2 0.0033 0.9365 
 0.0034 0.9711 
 0.0031 0.9548 
1 µM duplex, 2 µM PNAb, 1 µM MgCl2 0.0048 0.9566 
 0.0038 0.9642 
 0.0040 0.9524 
0.5 µM duplex, 1 µM PNAb, 3 µM MgCl2 0.0007 0.8962 
 0.0005 0.8094 
 0.0005 0.8810 
0.5 µM duplex, 1 µM PNAb, 12.5 µM MgCl2 0.0003 0.7875 
 0.0002 0.4584 
 0.0003 0.4507 
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 With three different concentrations we have have three different rates; r1, r2 and 
r3 defined as the average of the rate of the three replications of each condition. Using the 
method of initial rates we can isolate the exponents in the rate equation: 
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Likewise we use the ratio of r3 to r2 to determine the second exponent. Isolating 
the exponents results in values of 0.34 and 0.72 for X and Y respectively. This indicates a 
ratio of 2:1 PNA to DNA in the rate limiting step in accordance with previous reports on 
the invasion of poly-T PNA oligos into much longer DNA duplexes142 and could also 
indicate the formation of a PNA2:DNA triplex. Although PNA is known to form stable 
antiparallel  duplexes with complementary DNA and especially homopurine PNA has 
been shown to form a 1:1 PNA:DNA duplex,143 previous studies have also  reported on 
the formation of homopyrimidine PNA2:DNA triplexes,142 cytosine rich homopyrimidine 
PNA:DNA2 triplexes,144 alternating thymine-guanine PNA:DNA duplexes144 and 
conversely alternating thymine-guanine PNA2:DNA triplexes.145 A prominent factor in 
this variety of stoichiometric configurations is the increased stability of PNA Hoogsteen 
basepairs.146 
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Figure 38 - Basepair triads with Hoogsteen basepairs at the top. Notice that formation 
of the C:G Hoogsteen pairs requires protonation of the N3 of cytosine and the A:G 
requires protonation of N1 of adenine. Hence the propensity for this assembly can be 
probed by altering pH. Reproduced with permission.146  
The canonical Hoogsteen basepairing scheme results in a triplex with a Watson 
Crick purine-pyrimidine pair and pyrimidine binding in the major groove via 
Hoogsteen pairing but purine strands can also form Hoogsteen basepairs. See Figure 38. 
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In DNA triplexes the Hoogsteen strand binds parallel to the strand with which it 
basepairs. Likewise in homopyrimidine PNA2:DNA triplexes where the Hoogsteen 
strand binds in a parallel fashion to the homopurine DNA strand. However, these 
complexes are additionally stabilized by hydrogen bonds between the phosphor bound 
oxygen of the DNA strand and the amide hydrogen on the Hoogsteen strand. 147 
 
Figure 39 - Kinetic scheme from Wittung et al. Reproduced with permission .142   
Wittung et al. investigated the invasion of a homopyrimidine PNA into a DNA 
duplex but despite the final triplex they did not reach a conclusion concerning the rate 
limiting intermediate. The top row in Figure 39 illustrates one idea with an initial base 
dissociation in the DNA duplex followed by association of the first PNA strand and then 
a second PNA strand. Wittung et al. argue that the association of the second PNA strand 
(species 4) should energetically not be slower than species 2. To accommodate a rate 
limiting step with multiple PNA’s they also suggest a second scheme (Figure 39 bottom 
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row) consisting of several PNA’s associating with the DNA duplex both by invasion and 
Hoogsteen basepairing. In this scheme species 5’ and 6’ represent metastable structures 
with several PNA’s bound that slowly rearrange to the final product.  
The different possible confirmations make it difficult to probe the rate limiting 
step in the duplex invasion reaction. In the present case we are concerned with 
evaluating the salt dependence of the reaction and our rate equation allows for a relative 
investigation of this. 
Table 4 Rate constants for PNA invasion at different MgCl2 concentrations. 
 1 mM MgCl2 6 mM MgCl2 12.5 MgCl2 
k (s-1 M-1) 0.0025 0.00072 0.00034 
 
Considering this we then tried altering the concentration of MgCl2. Figure 37b 
shows representative graphs of the initial rates of duplex dissociation. Using the 
exponents determined we calculate the rate constants at different salt concentrations. See 
Table 4. We observe an increase in the rate constant of almost an order of magnitude 
when going from 1 mM MgCl2 to the 12.5 mM that is usually used for annealing DNA 
nanostructures. Utilizing this information we annealed TAE arrays with duplex invasion 
sites at 12.5 mM MgCl2 and then buffer exchanged the assembled structures with 1 mM 
MgCl2 at 4 °C. We then added biotinylated PNA equimolar to the concentration of 
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invasion sites and incubated for >2 hours before depositing on mica with 12.5 mM 
MgCl2 and 1-2 μM STV and imaged with AFM. 
 
Figure 40 AFM of PNA invasion in TX array (a) Control sample with biotinylated 
DNA. (b) TAE arrays incubated at 1 mM MgCl2 with biotin-PNA and then imaged 
with STV. (c) Zoom of array with section contour. The section is 412 nm and includes 
6 STV’s. 
 The control sample with biotinylated DNA added shows no STV localization to 
the arrays (Figure 40a) but the PNA sample shows the protein localized as beads on a 
string following invasion into the duplex by biotinylated PNA (Figure 40b). Figure 40c 
shows a zoom of an array with attached STV and a 412 nm section along the array. Each 
tile is 52 nucleotides long. At 0.33 nm per nucleotide in duplex DNA that makes for ~17 
nm per tile and 24 tiles in the 412 nm long array. With 6 STV’s bound this gives a yield 
of ~25% invasion sites successfully targeted. While a substantial variance is observed 
(Figure 40b) it seems clear that the level of duplex invasion within a nanostructure is 
substantially lower than the kinetics would suggest. While PNA holds promise as an 
orthogonal means of introducing dynamic behaviours in nano devices, more 
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experiments are needed in order to careful model duplex invading potential of PNA in 
the context of DNA nanostructures. 
6.3.4 Conclusion 
We have shown that positively charged PNA molecules behave differently than DNA in 
the context of DNA nanostructures as evidenced by the altered binding distribution on a 
two dimensional DNA origami. Positive PNA probes can exploit the large density of 
negative charge at the centre of DNA based nanostructures to more effectively bind 
targets with shorter complementary sequences. A feature that is essential when 
exploiting the lower scale-limit of DNA based nanotechnology and DNA based 
biomaterials. Furthermore the potential for strand invasion increases the toolbox for 
creating dynamic nanoscale DNA devices. However, more research is needed to better 
understand and model the invasion mechanism in order to create accurate and 
predictable nanoscale machinery. 
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7. Medical Impact and Future Directions 
One of the areas where TGF-β plays an important part is in wound healing. 
Following injury, a wide range of intracellular and intercellular pathways must be 
coordinated to restore tissue integrity. Wound repair is classically divided into three 
different stages. One; inflammation, two; new tissue formation and three; remodeling.148 
1) The first stage of “inflammation” typically lasts till about 24-48 hours after the 
injury. This stage is characterized by a type of cell fragments called platelets, 
clustering together and forming a plug. The coagulation cascade is then initiated 
resulting in fibrin being deposited on the plug, stopping blod loss and ahcieving 
haemostasis. Additionally the immunesystem is activated by invading pathogens 
and neutrophils are recruited to the site of injury. 
2)  The second stage called “new tissue formation” occurs 2-10 days after injury and 
involves cellular proliferation and migration leading to restoration of the 
epithelium. It also involves extensive production of extra cellular matrix (ECM) 
especially in the form of collagen. This new ECM is primarily produced by 
fibroblast cells as a response to TGF-β and other cytokines. This stage also sees 
the initiation of new blood vessel formation through the migration of endothelial 
cells. A process known as angiogenesis which is likewise stimulated by TGF-β 
and other cytokines. 149  
3) The final stage is “remodeling” which begins 2-3 weeks after injury and can last 
for more than a year. During this stage many cells either undergo apoptosis or 
migrate out of the wound area. This leaves a disorganized collagen matrix with a 
sparse population of fibroblasts constituting the scar tissue. 
The wound healing process is important in pathological conditions where it 
doesn’t function properly. This is the case in chronic wounds such as diabetic ulcers that 
are becoming more prevalent as more and more people develop diabetes.150 It was 
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estimated that 285 million people worldwide had diabetes in 2010 and this number is 
expected to rise to 439 by 2030. An increase from 6.4 to 7.7%.151 
The process of wound healing can also pose problems in other situations. In 
spinal cord injuries (SCI) a primary impediment for neuronal axon regrowth is the 
formation of collagen rich scar tissue.152  SCI recovery can be advanced by disrupting 
scar formation either by blocking the enzymatic pathway of collagen synthesis or by 
treatment with TGF-β inhibitory antibodies.152, 153 However, the wide range of cellular 
tasks that TGF-β partakes in means disrupting this signaling pathway can have 
detrimental consequences for recovery. For example; failure of angiogenesis leads to 
secondary degeneration of both neurons and glial cells but this process can be 
ameliorated by stimulating angiogenesis through treatment with cytokines.154 Since 
TGF-β is an important signaling molecule in angiogenesis, treatment with inhibitory 
antibodies towards TGF-β can be expected to have substantial negative consequences 
through the inhibition of angiogenesis. 
Wound healing isn’t just relevant in the case of actual visible wounds. An almost 
identical process occurs in practically any tissue that receives destructive stimuli. For 
example; following a myocardial infarction a similar process takes place in the heart 
tissue leading to the formation of scar tissue. Complications stemming from this 
formation kills close to 100,000 people in the US every year.148 If we can understand the 
wound healing process better and develop a technology that allow us to modulate it, we 
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could hope to address some of these issues. Be it in inducing the scar forming process in 
chronic wounds, or attenuating it following a heart attack. 
The wound healing process is orchestrated through the release of signaling 
chemicals by the cells in the wound area. These molecules are predominantly 
polypeptides classified as cytokines. Investigations of the expression of several such 
signaling molecules show distinct temporal patterns following injury. For example: In 
rat skin-burn injuries, Type I collagen expression remains low until a couple of days 
after injury when it starts to increase, consistent with the production of collagen in the 
second stage of wound healing. TGF-β displays a biphasic expression pattern that hints 
at its diverse functionality as a signaling molecule.155  
 In wound healing TGF-β plays a central role in both inducing expression of 
collagen, and more broadly inducing fibrosis and also inducing angiogenesis. This 
means that TGF-β manipulation can potentially both be used to promote wound healing 
and to prevent detrimental scar formation in cases such as spinal cord injury. The 
challenge is to have cell specific and temporal control. It might be advantages to limit 
collagen formation by fibroblast cells without preventing angiogenesis by endothelial 
cells. Application of TGF-β ligand to the wound results in an area wide stimulation as 
does application of TGF-β neutralizing antibodies. 
Our DNA nanostructure based technology holds promise as a way to modulate 
TGF-β stimulation as it allows for cell stimulation without modification of the systemic 
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level of TGF-β. This especially has potential as a therapeutic strategy if we can target our 
nano-assemblies to cell subpopulations. This has already been achieved with different 
structures trough convenient incorporation of aptamers.156 Further research should focus 
on proving sub-population specific interaction and sensitization of nano-assemblies as 
this holds great promise for medical applications. 
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8. Experimental 
8.1 Sensitization of Transforming Growth Factor-β Signaling by 
Multiple Peptides Patterned on DNA Nanostructures 
8.1.1 Nanostructure Assembly 
Rothemund’s tall rectangle origami37 was modified by redesigning and then 
biotinylating a select set of staple strands. 5 nM M13 ssDNA scaffold (Bayou Biolabs) 
were annealed with 5x concentration of staple strands (Integrated DNA Technologies) in 
1x TAE/Mg2+ (Tris, 40 mM; acetic acid, 20 mM; EDTA, 2 mM; and magnesium acetate, 
12.5 mM; pH 8.0) and annealed from 90 to 4°C over the course of 2 hours. Nano-
assemblies were assembled in stepwise fashion and separated from unassembled 
components using Microcon 100,000 MWCO filter2 spin units. Streptavidin was 
incubated overnight and biotinylated peptide LTGKNFPMFHRN-biotin (Eton 
Bioscience) was incubated for at least two hours at room temperature. Freshly prepared 
assemblies were added to cell cultures for a final estimated concentration (assuming no 
loss during filtration the step) of 300 pM. 
8.1.2 AFM 
5ul of diluted sample was pipetted onto freshly cleaved mica. AFM images were 
obtained on a Digital Instruments Nanoscope III (Vecco, USA) using NP–S oxide-
sharpened silicon nitride tips (Vecco, USA) with a Multimode head and fluid cell in 
tapping mode under buffer. 
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8.1.3 Cell Culture 
NMuMG cells were obtained from Duke University cell culture facility. They 
were cultured in DMEM media with 10% FBS, 50 units/ml penicillin, 50 µg/ml 
streptomycin and 10 µg/ml human or bovine insulin at 37°C and 5% CO2.  
8.1.4 Immunofluorescence 
Cells were grown on circular microscope cover slips (Ted Pella) in 24-well plates 
with 40 pM added background TGFβ (ProSpec) and specified treatments. The cells were 
treated with nano-assemblies for 18 hours before fixing. They were fixed in 4%  
paraformaldehyde/PBS for 15 min at 4°C, then permeabilized in 0.125% Trition X-
100/PBS for 15 min at room temperature followed by blocking in 3% BSA/PBS for 30 
min. Monoclonal mouse anti-Smad2/3 (clone 18, BD Biosciences Pharmingen, 1:200) was 
spotted onto parafilm and microscope slides inverted onto droplets and incubated 
overnight at 4°C. Following washing with PBS, secondary antibody Rhodamine Red-X 
goat anti-mouse IgG (H+L) (Life Technologies) was incubated for 1 hour at room 
temperature. After washing with PBS the samples were then stained with 300nM DAPI 
for ~5 min before washing again in PBS and mounting with Fluoromount-G (Southern 
Biotech). 
8.1.5 Luminescence Assay 
Smad2/3 response was quantified using Cignal SMAD Reporter Assay Kit 
(SABiosciences) which was transfected with Fugene6 (Promega) and developed with 
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Dual-Glo Luciferase assay system (Promega). Manufactures instructions were followed 
with reverse transfections (transfectant added first, followed by addition of cells) done 
in Opti-MEM media (Life Technologies) with 3% FBS and 1% NEAA (Life Technologies). 
Transfected cells were assayed in growth media with background TGFβ conc. of 40 pM. 
All data were collected as the mean of triplicate measurements, and the entire 
experiment was repeated three times. Luciferase luminescence was normalized to renilla 
luminesce controlled by a constitutively active promote as per the manufacterer’s 
instructions (SABiological). 
8.2 Functionalization of DNA Nanostructures with Zinc Finger Binding 
Peptides 
8.2.1 Design of TX Tile 
Design of the TX tile was based on a previous published structure. 157 The outer 
strands of the tile were modified with protruding hairpins containing the zinc finger 
target sequence and two pairs of flanking nucleotides. 4 T’s were incorporated to 
terminate the hairpin loop. Custom oligo nucleotides were purchased from Integrated 
DNA Technology (www.idtdna.com) and purified by PAGE. Structures were formed by 
mixing strands at approximate stoichiometric ratio in TAEMg (20 mM Tris, 2 mM 
EDTA, 12.5 mM MgCl2, acetic acid to pH 7.6) to a final concentration of 1 μM in 50 μl. 
The mixture was then placed in a 94 °C water bath and left to cool to room temperature 
during approximately 24 hours. 
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8.2.2 Protein Expression 
Protein was expressed and purified with the pMAL expression system from New 
England Biolabs (www.neb.com). Concentration was determined by measuring the 
absorbance and 280 nm and using the method of Gill and Hippel to calculate an 
extinction coefficient.158 Increasing the concentration was done with a 10 MWCO spin 
filter column from Amicon. 
8.2.3 ELISA Assay of Protein Expression 
Streptavidin coated 96 well plates were incubated with target sequence biotin-
GGC CAC TGC GGC TCC GGC CCC GAG TTT TCT CGG GGC CGG AGC CGC AGT 
GGC C and non-target sequence biotin-GGC GAC TCC GGC CGC CTC GGC GAG TTT 
TCT CGC CGA GGC GGC CGG AGT CGC C. Saturated with albumin and washed with 
PBST (137 mM NaCl, 2.7 mM Kl, 10 mM Na2HPO4, 2 mM KH2PO4, 0.1 % tween 20). 
Dilution series of freshly lysed cells expressing the constructs were then incubated for 
half an hour. Afterwards the 96-well plates were incubated first with anti-MBP 
antibodies raised in mice and then with anti-mouse antibodies raised in goat and fused 
to Alkaline Phosphatase (AP). Addition of AP developer (0.5 mg/ml pNPP disodium salt 
hexahydrate, 10 % w/v diethanolamine, 0.5 mM MgCl2) to the wells initiates the reaction 
which ran for approximately 1 hour where-after absorbance at 405 nm was recorded. 
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8.3 Functionalization and Modification of DNA Nanostructures with 
Peptide Nucleic Acid 
8.3.1 PNA Synthesis 
The PNA oligomer was synthesized by solid phase peptide synthesis using the 
Boc-protection strategy.159 MBHA resin was downloaded with Boc-L-Lys-(4-MeOBzl)-
OH (NovaBiochem) to an estimated loading of 0.05 mequiv/g. Boc group on resin is 
deprotected with 5 % m-cresol in trifluoroacetic acid (TFA). According to the sequence of 
the PNA oligomer, a Boc-protected PNA monomer (A, G, T, or C) (ASM Research 
Chemicals) was coupled to the resin using O-Benzotriazole-N,N,N’,N’-
tetramethyluronium hexafluoro-phosphate (HBTU) (Peptides International) as a 
coupling agent. Unreacted –NH2 sites on resin were capped by acetic anhydride. Finally, 
5-aminovaleric acid (C4) as a linker and 3-mercaptopropionic acid (C2) as a source of –SH 
group were coupled at the end of the PNA oligomer to allow the functionalization of 
biotin. PNA oligomers were cleaved from the resin with TFA and 
trifluoromethanesulfonic acid (TFMSA), precipitated in diethyl ether, and dried with 
nitrogen. PNA oligomers were purified by reversed-phase HPLC using a C18 silica 
column on a Waters 600 model. Absorbance was measured at 260 nm with a Waters 2996 
Photodiode Array Detector. Characterization of the oligomers was performed by 
MALDI-ToF mass spectrometry on an Applied Biosystems Voyager Biospectrometry 
Workstation with Delayed Extraction and an R-cyano-4-hydroxycinnamic acid matrix 
(10 mg/mL in 1:1 water/acetonitrile, 0.1% TFA). PNA sequence synthesized for this 
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study is Lys3-ATGAATATAGTTGGGA-C4C4C2. m/z for the PNA molecule (M+H)+ were 
calculated and found to be 5127.2/5130.0. PNA solutions were prepared in nanopure water 
(>18.3 MΩ cm-1) and stored at -18 °C to avoid depurination reactions. The concentration of 
PNA stock solution were determined by UV-Vis spectrophotometry using ε(260) = 6600, 
8600, 11 700, and 13 700 cm-1 M-1 for each C, T, G, and A monomer, respectively. For 
biotinylation the PNA was first reduced using immobilized TCEP (Thermo Scientific) 
and then biotinylated with EZ-Link Maleimide-PEG2-Biotin2 (Thermo Scientific). The 
final product was purified by reverse phase HPLC. 
8.3.2 UV-Vis Melting Curves 
UV melting curves were recorded at 260 nm in the temperature range of 10-95 °C 
for both cooling and heating modes, at the rate of 1 °C/min. Prior to the measurement of 
the melting profiles, solutions of 3 µM of each ssPNA in 1X TAE and different 
concentration of MgCl2 were kept at 95 °C for 10 min before cooling down. Tm is the 
inflection point of a sigmoidal function used to fit the melting curve. DNA strands were 
purchased from Integrated DNA Technologies. 
8.3.3 Nanostructure Assembly 
All DNA strands were purchased from Integrated DNA Technologies. Origami 
samples were annealed from 90 to 20°C over two hours in TAE/Mg2+ (Tris, 40 mM; acetic 
acid, 20 mM; EDTA, 2 mM; and magnesium acetate, 12.5 mM; pH 8.0) with 5 nM M13 
scaffold, 50 nM staple strand and 200 nM PNA or DNA control strands. Following 
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anneal the samples were spun filtered with Microcon 100,000 MWCO filter spin units at 
4°C and subsequently kept on ice until prepped for AFM. TAE arrays were annealed 
with 200 nM of each strand from 90 to 20°C over 8 hours. Following anneal the sample 
was buffer exchanged into TAE buffer with 1 mM MgCl2 at 4°C. PNA or DNA control 
oligo was then added to 200 nM and incubated for more than 2 hours. Then bought to 
12.5 mM MgCl2 before imaging with AFM. 
8.3.4 AFM 
Origami samples were mixed with 1-2 μM STV and incubated at room 
temperature for 1-2 hours. Then 5 μl sample was deposited on freshly cleaved mica. TAE 
array samples were put directly on freshly cleaved mica and then STV was added to a 
concentration of 1-2 μM. AFM images were obtained on a Digital Instruments 
Nanoscope III (Vecco, USA) using NP–S oxide-sharpened silicon nitride tips (Vecco, 
USA) with a multimode head and fluid cell in tapping mode under buffer. 
8.3.5 Fluorescence 
Fluorescence data were collected using a Cary Eclipse Fluorescence Spectrophotometer 
from Varian, with temperature controller set to 23°C. Excitation and emission 
wavelengths were 648 and 668 nm with a 5 nm bandwidth. Complementary DNA 
strands with fluorophore “Cy5” and quencher “Iowa Black RQ” were purchased from 
IDT and pre-annealed in TAE buffer with specified MgCl2 concentration by incubating 
at 90 °C for 5 min and then cooling to room temperature. PNA was added and mixed 
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within a 10 sec period and data points were recorded every 0.1 sec and subsequently 
averaged with a three data point period. Fluorescence data was translated to 
concentration values by setting base level to 0 μM dissociated duplex and recording 
maximum fluorescence following thermal melting and annealing of duplex with PNA 
and taking this to correspond with full dissociation of DNA duplex. A 10 second period 
following mixing was used to fit a linear equation giving the initial rate of reaction. All 
rates were measured in triplicate and the average used to calculate the exponents in the 
rate equation. 
 91 
Appendix A – Additional Micrographs 
Supplemental Micrographs of NMuMG Cells Treated with Nanostructures and 
Controls 
Below follows additional micrographs of cell treated with nano assemblies and 
controls.Top of each image is Smad2/3 stain, middle is DAPI stain and bottom is a 
merged image of the two preceeding.  
 
Figure 41 Control sample with background TGFβ level of 40 pM. Top: Smad3/4 stain. 
Middle: DAPI stain. Bottom: merged. 
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Figure 42 Control sample treated with 3 nM streptavidin and 12 nM peptide 
premixed and 40 pM TGFβ. Top: Smad3/4 stain. Middle: DAPI stain. Bottom: merged. 
 
Figure 43 Control sample treated with 12 nM peptide and 40 pM TGFβ. Top: 
Smad3/4 stain. Middle: DAPI stain. Bottom: merged. 
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Figure 44 Sample treated with nano assembly and 40 pM TGFβ. Top: Smad3/4 
stain. Middle: DAPI stain. Bottom: merged. 
 
Figure 45 Positive control treated with 200 pM TGFβ. Top: Smad3/4 stain. 
Middle: DAPI stain. Bottom: merged. 
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AFM Micrographs of Biotinylated PNA Incorporated in Origami 
Fully formed structures wholly in each micrograph were counted. Structures not 
fully formed were not counted and are marked with a yellow cross. Centre located 
streptavidin is marked with a red circle, side located with a blue circle and corner 
located with a green circle. 
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AFM Micrographs of Biotinylated DNA control Incorporated in 
Origami 
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Appendix B – DNA Sequences 
TGF-β Origami Sequences 
Strands t-1r14f, t-1r16f, t-1r18f, t-1r20f, t-1r14e, t1r14f, t-1r16e, t1r16f, t-1r18e, t1r18f, t-
1r20e and t1r20f from the tall rectangle was substituted with the following strands: 
A_CR: biotin-TT AA AGC GAA AGT TTC AT TCC ATA TAT TTA GTT T  
B_CR: biotin-TT GA CCA TTA AGC ATA AAGCT AAA TCC TTT TGC G 
C_CR: biotin-TT GG AGA AGC CCG GAG AG GGT AGC TAT TGC CTG A 
AS1: AAG AGG AAC GAG CTT C 
AS2: GA GTC TGG TTA AAT CA 
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D_CR: biotin-TT GA CTT CAA CAA GAA CG- GGT ATT AAT CTT TCC T 
E_CR: biotin-TT TT CCC AAT ATT TAG GC-AGA GGC ATA CAA CGC C 
F_CR: biotin-TT CA AAA ACA CAA ATA TA-TTT TAG TTC GCG AGA A 
G_CR: biotin-TT AG ATC TAC CCT TGC TT-CTG TAA ATA TAT GTG A 
AS3: GT GAA TAA AAA GGC TA-TCA GGT CAT TTT TGA G 
H_CR: biotin-TT TA TCA TTC ATA TCG CG-TTT TAA TTG CCC GAA A 
I_CR: biotin-TT AA CAT GTA TCT GCG AA-CGA GTA GAA CAG TTG A 
J_CR: biotin-TT AA CTT TTT TTA TGA CC-CTG TAA TAG GTT GTA C 
 
Zinc Finger DNA Sequences 
TX Tile Sequences 
Strand 1: 
GCAGACCGTAGAATCGCCTGCTCTGTATGTCACTGCGGCTCCGGCCCCAGTTT
TCTGGGGCCGGAGCCGCAGTGACTTTGCCGAACTGG-ACACTTACCTCTA 
Strand 2:  
ACGACTAATCCGTCTTGTGGCGATTCTACGG 
Strand 3: 
ATGTCGCACCAGTTCGGCAATACAGAGCACCAGTGGCATTCGGAGAT 
Strand 4: 
TCTGCTAGAGGTAAGTGTGGAGTGGAACAAGTAACCGCAACGCACCAAGGCT 
Strand5: 
 107 
GTCGTTATCGTGGACTCCTGCGACATAGCCTTGGACTGGACAAGACGGATTA 
Strand 6: 
GGCTTACAATGAACGGCACCACGATA 
Strand 7: 
AAGCCATCTCCGAATGCCTGCGTTGCGGTTGGGAGCCGGAGCCGGAGTCAGT
TTTCTGACTCCGGCTCCGGCTCCCATTTACTTGTTCC-TGCCGTTCATTGTA 
Origami Sequence 
The staple strand t-5r2f is substituted with the two strands below: 
5’ t-5r2f:  
TGAGTTTCAAAGGAACTTTTGGCCACTGCGGCTCCGGCCCCGAGTTTTCTCGGG
GCCGGAGCCGCAGTG GCC 
3` t-5r2f:  
AACTAAAGATCTCCAA 
PNA DNA sequences 
Origami Strands 
Centre strands t-1r16e and t1r16f were substituted with  
PNA_E_CR_V: TCAACCCT - TT CCC AAT ATT TAG GC-AGA GGC ATA CAA CGC C 
PNA_I_CR_V: AA CAT GTA TCT GCG AA-CGA GTA GAA CAG TTG A TACTTATA 
 
Corner strand t7r29f was substituted with 
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PNA_7: CTA CAT TTT GAC GCT CAC GCT CAT GGA AAT AC TTT 
TACTTATATCAACCCT 
 
For the side position on the M13 scaffold the staple stran; t1r0g was left out   
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